Item 1. FINANCIAL STATEMENTS
158K characters. Original on sec.gov ·
Item 1. FINANCIAL STATEMENTS
Dow Inc. and Subsidiaries
Consolidated Statements of Income
| Three Months Ended | Nine Months Ended | |||||||||||||
| In millions, except per share amounts (Unaudited) | Sep 30, 2026 | Sep 30, 2025 | Sep 30, 2026 | Sep 30, 2025 | ||||||||||
| Net sales | $ | 11,267 | $ | 9,973 | $ | 33,153 | $ | 30,508 | ||||||
| Cost of sales | 9,889 | 9,242 | 28,968 | 28,523 | ||||||||||
| Research and development expenses | 180 | 191 | 568 | 579 | ||||||||||
| Selling, general and administrative expenses | 408 | 340 | 1,360 | 1,053 | ||||||||||
| Amortization of intangibles | 40 | 46 | 126 | 185 | ||||||||||
| Restructuring and asset related charges - net | 9 | 23 | 539 | 822 | ||||||||||
| Equity in earnings (losses) of nonconsolidated affiliates | 12 | (72) | (255) | (122) | ||||||||||
| Sundry income (expense) - net | 50 | 185 | 296 | 345 | ||||||||||
| Interest income | 50 | 47 | 130 | 114 | ||||||||||
| Interest expense and amortization of debt discount | 211 | 221 | 640 | 646 | ||||||||||
| Income (loss) before income taxes | 642 | 70 | 1,123 | (963) | ||||||||||
| Provision (credit) for income taxes | 117 | (54) | 241 | 4 | ||||||||||
| Net income (loss) | 525 | 124 | 882 | (967) | ||||||||||
| Net income attributable to noncontrolling interests | 67 | 62 | 236 | 113 | ||||||||||
| Net income (loss) available for Dow Inc. common stockholders | $ | 458 | $ | 62 | $ | 646 | $ | (1,080) | ||||||
| Per common share data: | ||||||||||||||
| Earnings (loss) per common share - basic | $ | 0.63 | $ | 0.08 | $ | 0.88 | $ | (1.53) | ||||||
| Earnings (loss) per common share - diluted | $ | 0.62 | $ | 0.08 | $ | 0.88 | $ | (1.53) | ||||||
| Weighted-average common shares outstanding - basic | 725.5 | 711.8 | 723.4 | 709.4 | ||||||||||
| Weighted-average common shares outstanding - diluted | 727.4 | 713.2 | 724.8 | 709.4 | ||||||||||
| Depreciation | $ | 485 | $ | 536 | $ | 1,512 | $ | 1,586 | ||||||
| Capital expenditures | $ | 706 | $ | 564 | $ | 1,841 | $ | 1,911 |
See Notes to the Consolidated Financial Statements.
Dow Inc. and Subsidiaries
Consolidated Statements of Comprehensive Income
| Three Months Ended | Nine Months Ended | |||||||||||||
| In millions (Unaudited) | Sep 30, 2026 | Sep 30, 2025 | Sep 30, 2026 | Sep 30, 2025 | ||||||||||
| Net income (loss) | $ | 525 | $ | 124 | $ | 882 | $ | (967) | ||||||
| Other comprehensive income (loss), net of tax | ||||||||||||||
| Unrealized gains (losses) on investments | (89) | 57 | (37) | 67 | ||||||||||
| Cumulative translation adjustments | 14 | (33) | (88) | 218 | ||||||||||
| Pension and other postretirement benefit plans | 33 | 28 | 106 | 69 | ||||||||||
| Derivative instruments | 50 | 11 | 25 | (7) | ||||||||||
| Total other comprehensive income | 8 | 63 | 6 | 347 | ||||||||||
| Comprehensive income (loss) | 533 | 187 | 888 | (620) | ||||||||||
| Comprehensive income attributable to noncontrolling interests, net of tax | 67 | 62 | 236 | 113 | ||||||||||
| Comprehensive income (loss) attributable to Dow Inc. | $ | 466 | $ | 125 | $ | 652 | $ | (733) |
See Notes to the Consolidated Financial Statements.
Dow Inc. and Subsidiaries
Consolidated Balance Sheets
| In millions, except share amounts (Unaudited) | Sep 30, 2026 | Dec 31, 2025 | ||||||
| Assets | ||||||||
| Current Assets | ||||||||
| Cash and cash equivalents (variable interest entities restricted - 2026: $266; 2025: $31) | $ | 4,142 | $ | 3,816 | ||||
| Accounts and notes receivable: | ||||||||
| Trade (net of allowance for doubtful receivables - 2026: $66; 2025: $59) | 5,890 | 4,762 | ||||||
| Other | 1,717 | 1,876 | ||||||
| Inventories | 7,024 | 6,595 | ||||||
| Other current assets | 1,404 | 1,013 | ||||||
| Total current assets (variable interest entities restricted - 2026: $471; 2025: $228) | 20,177 | 18,062 | ||||||
| Investments | ||||||||
| Investment in nonconsolidated affiliates | 1,119 | 1,264 | ||||||
| Other investments (investments carried at fair value - 2026: $2,320; 2025: $2,212) | 3,201 | 3,017 | ||||||
| Noncurrent receivables | 612 | 309 | ||||||
| Total investments | 4,932 | 4,590 | ||||||
| Property | ||||||||
| Property | 67,209 | 65,863 | ||||||
| Less: Accumulated depreciation | 44,811 | 43,613 | ||||||
| Net property (variable interest entities restricted - 2026: $2,330; 2025: $2,385) | 22,398 | 22,250 | ||||||
| Other Assets | ||||||||
| Goodwill | 7,945 | 7,978 | ||||||
| Other intangible assets (net of accumulated amortization - 2026: $5,882; 2025: $5,727) | 1,318 | 1,486 | ||||||
| Operating lease right-of-use assets | 1,304 | 1,356 | ||||||
| Deferred income tax assets | 1,555 | 1,511 | ||||||
| Deferred charges and other assets | 1,324 | 1,305 | ||||||
| Total other assets (variable interest entities restricted - 2026: $204; 2025: $226) | 13,446 | 13,636 | ||||||
| Total Assets | $ | 60,953 | $ | 58,538 | ||||
| Liabilities and Equity | ||||||||
| Current Liabilities | ||||||||
| Notes payable | $ | 16 | $ | 90 | ||||
| Long-term debt due within one year | 745 | 222 | ||||||
| Accounts payable: | ||||||||
| Trade | 5,300 | 4,151 | ||||||
| Other | 1,363 | 1,394 | ||||||
| Operating lease liabilities - current | 341 | 340 | ||||||
| Income taxes payable | 367 | 337 | ||||||
| Accrued and other current liabilities | 3,361 | 2,649 | ||||||
| Total current liabilities (variable interest entities nonrecourse - 2026: $503; 2025: $438) | 11,493 | 9,183 | ||||||
| Long-Term Debt (variable interest entities nonrecourse - 2026: $173; 2025: $190) | 16,778 | 17,849 | ||||||
| Other Noncurrent Liabilities | ||||||||
| Deferred income tax liabilities | 368 | 364 | ||||||
| Pension and other postretirement benefits - noncurrent | 4,318 | 4,694 | ||||||
| Asbestos-related liabilities - noncurrent | 564 | 628 | ||||||
| Operating lease liabilities - noncurrent | 1,028 | 1,097 | ||||||
| Other noncurrent obligations | 8,772 | 7,201 | ||||||
| Total other noncurrent liabilities (variable interest entities nonrecourse - 2026: $331; 2025: $364) | 15,050 | 13,984 | ||||||
| Stockholders’ Equity | ||||||||
| Common stock (authorized 5,000,000,000 shares of $0.01 par value each; issued 2026: 791,927,232 shares; 2025: 790,287,565 shares) | 8 | 8 | ||||||
| Additional paid-in capital | 11,060 | 11,112 | ||||||
| Retained earnings | 16,659 | 16,781 | ||||||
| Accumulated other comprehensive loss | (7,654) | (7,660) | ||||||
| Treasury stock at cost (2026: 68,045,325 shares; 2025: 73,065,152 shares) | (3,920) | (4,233) | ||||||
| Dow Inc.’s stockholders’ equity | 16,153 | 16,008 | ||||||
| Noncontrolling interests | 1,479 | 1,514 | ||||||
| Total equity | 17,632 | 17,522 | ||||||
| Total Liabilities and Equity | $ | 60,953 | $ | 58,538 |
See Notes to the Consolidated Financial Statements.
Dow Inc. and Subsidiaries
Consolidated Statements of Cash Flows
| In millions (Unaudited) | Nine Months Ended | |||||||
| Sep 30, 2026 | Sep 30, 2025 | |||||||
| Operating Activities | ||||||||
| Net income (loss) | $ | 882 | $ | (967) | ||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | ||||||||
| Depreciation and amortization | 2,049 | 2,126 | ||||||
| Credit for deferred income tax | (94) | (179) | ||||||
| Earnings of nonconsolidated affiliates less than dividends received | 534 | 312 | ||||||
| Net periodic pension benefit credit | (25) | (73) | ||||||
| Pension contributions | (138) | (145) | ||||||
| Net gain on sales of assets, businesses and investments | (48) | (211) | ||||||
| Restructuring and asset related charges - net | 539 | 822 | ||||||
| Other net loss | 109 | 134 | ||||||
| Changes in assets and liabilities, net of effects of acquired and divested companies: | ||||||||
| Accounts and notes receivable | (1,214) | (400) | ||||||
| Inventories | (429) | (132) | ||||||
| Accounts payable | 1,014 | (492) | ||||||
| Other assets and liabilities, net | 1,108 | (31) | ||||||
| Cash provided by operating activities - continuing operations | 4,287 | 764 | ||||||
| Cash provided by (used for) operating activities - discontinued operations | 6 | (16) | ||||||
| Cash provided by operating activities | 4,293 | 748 | ||||||
| Investing Activities | ||||||||
| Capital expenditures | (1,841) | (1,911) | ||||||
| Proceeds from incentives related to capital expenditures | 67 | 132 | ||||||
| Cash flow hedging related to capital expenditures | (22) | — | ||||||
| Investment in gas field developments | (69) | (110) | ||||||
| Proceeds from sales of property, businesses and consolidated companies, net of cash divested | 60 | 135 | ||||||
| Investments in and loans to nonconsolidated affiliates | (133) | (21) | ||||||
| Proceeds from sales of ownership interests in nonconsolidated affiliates | — | 125 | ||||||
| Purchases of investments | (1,090) | (523) | ||||||
| Proceeds from sales and maturities of investments | 675 | 711 | ||||||
| Other investing activities, net | 61 | 5 | ||||||
| Cash used for investing activities | (2,292) | (1,457) | ||||||
| Financing Activities | ||||||||
| Changes in short-term notes payable | 1 | 36 | ||||||
| Proceeds from issuance of short-term debt greater than three months | 20 | 50 | ||||||
| Payments on short-term debt greater than three months | (92) | (46) | ||||||
| Proceeds from issuance of long-term debt | 100 | 2,652 | ||||||
| Payments on long-term debt | (577) | (1,207) | ||||||
| Collections on securitization programs, net of remittances | — | (3) | ||||||
| Transaction financing, debt issuance and other costs | (52) | (130) | ||||||
| Employee taxes paid for share-based payment arrangements | (15) | (16) | ||||||
| Distributions to noncontrolling interests | (232) | (93) | ||||||
| Proceeds from sale of noncontrolling interests | — | 2,943 | ||||||
| Dividends paid to stockholders | (758) | (1,239) | ||||||
| Other financing activities, net | — | (6) | ||||||
| Cash provided by (used for) financing activities | (1,605) | 2,941 | ||||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | (76) | 259 | ||||||
| Summary | ||||||||
| Increase in cash, cash equivalents and restricted cash | 320 | 2,491 | ||||||
| Cash, cash equivalents and restricted cash at beginning of period | 3,952 | 2,263 | ||||||
| Cash, cash equivalents and restricted cash at end of period | $ | 4,272 | $ | 4,754 | ||||
| Less: Restricted cash and cash equivalents, included in "Other current assets" | 130 | 145 | ||||||
| Cash and cash equivalents at end of period | $ | 4,142 | $ | 4,609 |
See Notes to the Consolidated Financial Statements.
Dow Inc. and Subsidiaries
Consolidated Statements of Equity
| Three Months Ended | Nine Months Ended | |||||||||||||
| In millions, except per share amounts (Unaudited) | Sep 30, 2026 | Sep 30, 2025 | Sep 30, 2026 | Sep 30, 2025 | ||||||||||
| Common Stock | ||||||||||||||
| Balance at beginning and end of period | $ | 8 | $ | 8 | $ | 8 | $ | 8 | ||||||
| Additional Paid-in Capital | ||||||||||||||
| Balance at beginning of period | 11,073 | 10,758 | 11,112 | 9,203 | ||||||||||
| Stock-based compensation | 83 | 97 | 261 | 293 | ||||||||||
| Treasury stock issuances - compensation and benefit plans | (96) | (96) | (313) | (276) | ||||||||||
| Sale of membership interest in Diamond Infrastructure Solutions | — | 339 | — | 1,879 | ||||||||||
| Other | — | 1 | — | — | ||||||||||
| Balance at end of period | 11,060 | 11,099 | 11,060 | 11,099 | ||||||||||
| Retained Earnings | ||||||||||||||
| Balance at beginning of period | 16,457 | 18,766 | 16,781 | 20,909 | ||||||||||
| Net income (loss) available for Dow Inc. common stockholders | 458 | 62 | 646 | (1,080) | ||||||||||
| Dividends to stockholders | (253) | (249) | (758) | (1,239) | ||||||||||
| Other | (3) | (3) | (10) | (14) | ||||||||||
| Balance at end of period | 16,659 | 18,576 | 16,659 | 18,576 | ||||||||||
| Accumulated Other Comprehensive Loss | ||||||||||||||
| Balance at beginning of period | (7,662) | (7,826) | (7,660) | (8,110) | ||||||||||
| Other comprehensive income | 8 | 63 | 6 | 347 | ||||||||||
| Balance at end of period | (7,654) | (7,763) | (7,654) | (7,763) | ||||||||||
| Treasury Stock | ||||||||||||||
| Balance at beginning of period | (4,016) | (4,475) | (4,233) | (4,655) | ||||||||||
| Treasury stock issuances - compensation and benefit plans | 96 | 96 | 313 | 276 | ||||||||||
| Balance at end of period | (3,920) | (4,379) | (3,920) | (4,379) | ||||||||||
| Dow Inc.'s stockholders' equity | 16,153 | 17,541 | 16,153 | 17,541 | ||||||||||
| Noncontrolling Interests | 1,479 | 1,523 | 1,479 | 1,523 | ||||||||||
| Total Equity | $ | 17,632 | $ | 19,064 | $ | 17,632 | $ | 19,064 | ||||||
| Dividends declared per share of common stock | $ | 0.35 | $ | 0.35 | $ | 1.05 | $ | 1.75 |
See Notes to the Consolidated Financial Statements.
The Dow Chemical Company and Subsidiaries
Consolidated Statements of Income
| Three Months Ended | Nine Months Ended | |||||||||||||
| In millions (Unaudited) | Sep 30, 2026 | Sep 30, 2025 | Sep 30, 2026 | Sep 30, 2025 | ||||||||||
| Net sales | $ | 11,267 | $ | 9,973 | $ | 33,153 | $ | 30,508 | ||||||
| Cost of sales | 9,888 | 9,241 | 28,965 | 28,520 | ||||||||||
| Research and development expenses | 180 | 191 | 568 | 579 | ||||||||||
| Selling, general and administrative expenses | 408 | 340 | 1,360 | 1,053 | ||||||||||
| Amortization of intangibles | 40 | 46 | 126 | 185 | ||||||||||
| Restructuring and asset related charges - net | 9 | 23 | 539 | 822 | ||||||||||
| Equity in earnings (losses) of nonconsolidated affiliates | 12 | (72) | (255) | (122) | ||||||||||
| Sundry income (expense) - net | 50 | 184 | 289 | 360 | ||||||||||
| Interest income | 50 | 47 | 131 | 117 | ||||||||||
| Interest expense and amortization of debt discount | 211 | 221 | 640 | 646 | ||||||||||
| Income (loss) before income taxes | 643 | 70 | 1,120 | (942) | ||||||||||
| Provision (credit) for income taxes | 117 | (54) | 241 | 4 | ||||||||||
| Net income (loss) | 526 | 124 | 879 | (946) | ||||||||||
| Net income attributable to noncontrolling interests | 67 | 62 | 236 | 113 | ||||||||||
| Net income (loss) available for The Dow Chemical Company common stockholder | $ | 459 | $ | 62 | $ | 643 | $ | (1,059) | ||||||
| Depreciation | $ | 485 | $ | 536 | $ | 1,512 | $ | 1,586 | ||||||
| Capital expenditures | $ | 706 | $ | 564 | $ | 1,841 | $ | 1,911 |
See Notes to the Consolidated Financial Statements.
The Dow Chemical Company and Subsidiaries
Consolidated Statements of Comprehensive Income
| Three Months Ended | Nine Months Ended | |||||||||||||
| In millions (Unaudited) | Sep 30, 2026 | Sep 30, 2025 | Sep 30, 2026 | Sep 30, 2025 | ||||||||||
| Net income (loss) | $ | 526 | $ | 124 | $ | 879 | $ | (946) | ||||||
| Other comprehensive income (loss), net of tax | ||||||||||||||
| Unrealized gains (losses) on investments | (89) | 57 | (37) | 67 | ||||||||||
| Cumulative translation adjustments | 14 | (33) | (88) | 218 | ||||||||||
| Pension and other postretirement benefit plans | 33 | 28 | 106 | 69 | ||||||||||
| Derivative instruments | 50 | 11 | 25 | (7) | ||||||||||
| Total other comprehensive income | 8 | 63 | 6 | 347 | ||||||||||
| Comprehensive income (loss) | 534 | 187 | 885 | (599) | ||||||||||
| Comprehensive income attributable to noncontrolling interests, net of tax | 67 | 62 | 236 | 113 | ||||||||||
| Comprehensive income (loss) attributable to The Dow Chemical Company | $ | 467 | $ | 125 | $ | 649 | $ | (712) |
See Notes to the Consolidated Financial Statements.
The Dow Chemical Company and Subsidiaries
Consolidated Balance Sheets
| In millions, except share amounts (Unaudited) | Sep 30, 2026 | Dec 31, 2025 | ||||||
| Assets | ||||||||
| Current Assets | ||||||||
| Cash and cash equivalents (variable interest entities restricted - 2026: $266; 2025: $31) | $ | 4,142 | $ | 3,816 | ||||
| Accounts and notes receivable: | ||||||||
| Trade (net of allowance for doubtful receivables - 2026: $66; 2025: $59) | 5,890 | 4,762 | ||||||
| Other | 1,718 | 1,880 | ||||||
| Inventories | 7,024 | 6,595 | ||||||
| Other current assets | 1,350 | 974 | ||||||
| Total current assets (variable interest entities restricted - 2026: $471; 2025: $228) | 20,124 | 18,027 | ||||||
| Investments | ||||||||
| Investment in nonconsolidated affiliates | 1,119 | 1,264 | ||||||
| Other investments (investments carried at fair value - 2026: $2,320; 2025: $2,212) | 3,201 | 3,017 | ||||||
| Noncurrent receivables | 606 | 303 | ||||||
| Total investments | 4,926 | 4,584 | ||||||
| Property | ||||||||
| Property | 67,209 | 65,863 | ||||||
| Less accumulated depreciation | 44,811 | 43,613 | ||||||
| Net property (variable interest entities restricted - 2026: $2,330; 2025: $2,385) | 22,398 | 22,250 | ||||||
| Other Assets | ||||||||
| Goodwill | 7,945 | 7,978 | ||||||
| Other intangible assets (net of accumulated amortization - 2026: $5,882; 2025: $5,727) | 1,318 | 1,486 | ||||||
| Operating lease right-of-use assets | 1,304 | 1,356 | ||||||
| Deferred income tax assets | 1,555 | 1,511 | ||||||
| Deferred charges and other assets | 1,324 | 1,305 | ||||||
| Total other assets (variable interest entities restricted - 2026: $204; 2025: $226) | 13,446 | 13,636 | ||||||
| Total Assets | $ | 60,894 | $ | 58,497 | ||||
| Liabilities and Equity | ||||||||
| Current Liabilities | ||||||||
| Notes payable | $ | 16 | $ | 90 | ||||
| Long-term debt due within one year | 745 | 222 | ||||||
| Accounts payable: | ||||||||
| Trade | 5,300 | 4,151 | ||||||
| Other | 1,363 | 1,394 | ||||||
| Operating lease liabilities - current | 341 | 340 | ||||||
| Income taxes payable | 367 | 337 | ||||||
| Accrued and other current liabilities | 3,247 | 2,542 | ||||||
| Total current liabilities (variable interest entities nonrecourse - 2026: $503; 2025: $438) | 11,379 | 9,076 | ||||||
| Long-Term Debt (variable interest entities nonrecourse - 2026: $173; 2025: $190) | 16,778 | 17,849 | ||||||
| Other Noncurrent Liabilities | ||||||||
| Deferred income tax liabilities | 368 | 364 | ||||||
| Pension and other postretirement benefits - noncurrent | 4,318 | 4,694 | ||||||
| Asbestos-related liabilities - noncurrent | 564 | 628 | ||||||
| Operating lease liabilities - noncurrent | 1,028 | 1,097 | ||||||
| Other noncurrent obligations | 8,639 | 7,063 | ||||||
| Total other noncurrent liabilities (variable interest entities nonrecourse - 2026: $331; 2025: $364) | 14,917 | 13,846 | ||||||
| Stockholder's Equity | ||||||||
| Common stock (authorized and issued 100 shares of $0.01 par value each) | — | — | ||||||
| Additional paid-in capital | 12,218 | 11,957 | ||||||
| Retained earnings | 11,777 | 11,915 | ||||||
| Accumulated other comprehensive loss | (7,654) | (7,660) | ||||||
| The Dow Chemical Company’s stockholder's equity | 16,341 | 16,212 | ||||||
| Noncontrolling interests | 1,479 | 1,514 | ||||||
| Total equity | 17,820 | 17,726 | ||||||
| Total Liabilities and Equity | $ | 60,894 | $ | 58,497 |
See Notes to the Consolidated Financial Statements.
The Dow Chemical Company and Subsidiaries
Consolidated Statements of Cash Flows
| In millions (Unaudited) | Nine Months Ended | |||||||
| Sep 30, 2026 | Sep 30, 2025 | |||||||
| Operating Activities | ||||||||
| Net income (loss) | $ | 879 | $ | (946) | ||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | ||||||||
| Depreciation and amortization | 2,049 | 2,126 | ||||||
| Credit for deferred income tax | (94) | (179) | ||||||
| Earnings of nonconsolidated affiliates less than dividends received | 534 | 312 | ||||||
| Net periodic pension benefit credit | (25) | (73) | ||||||
| Pension contributions | (138) | (145) | ||||||
| Net gain on sales of assets, businesses and investments | (48) | (211) | ||||||
| Restructuring and asset related charges - net | 539 | 822 | ||||||
| Other net loss | 110 | 136 | ||||||
| Changes in assets and liabilities, net of effects of acquired and divested companies: | ||||||||
| Accounts and notes receivable | (1,214) | (400) | ||||||
| Inventories | (429) | (132) | ||||||
| Accounts payable | 1,014 | (492) | ||||||
| Other assets and liabilities, net | 1,129 | (72) | ||||||
| Cash provided by operating activities | 4,306 | 746 | ||||||
| Investing Activities | ||||||||
| Capital expenditures | (1,841) | (1,911) | ||||||
| Proceeds from incentives related to capital expenditures | 67 | 132 | ||||||
| Cash flow hedging related to capital expenditures | (22) | — | ||||||
| Investment in gas field developments | (69) | (110) | ||||||
| Proceeds from sales of property, businesses and consolidated companies, net of cash divested | 60 | 135 | ||||||
| Investments in and loans to nonconsolidated affiliates | (133) | (21) | ||||||
| Proceeds from sales of ownership interests in nonconsolidated affiliates | — | 125 | ||||||
| Purchases of investments | (1,090) | (523) | ||||||
| Proceeds from sales and maturities of investments | 675 | 711 | ||||||
| Other investing activities, net | 61 | 5 | ||||||
| Cash used for investing activities | (2,292) | (1,457) | ||||||
| Financing Activities | ||||||||
| Changes in short-term notes payable | 1 | 36 | ||||||
| Proceeds from issuance of short-term debt greater than three months | 20 | 50 | ||||||
| Payments on short-term debt greater than three months | (92) | (46) | ||||||
| Proceeds from issuance of long-term debt | 100 | 2,652 | ||||||
| Payments on long-term debt | (577) | (1,207) | ||||||
| Collections on securitization programs, net of remittances | — | (3) | ||||||
| Transaction financing, debt issuance and other costs | (52) | (130) | ||||||
| Employee taxes paid for share-based payment arrangements | (15) | (16) | ||||||
| Distributions to noncontrolling interests | (232) | (93) | ||||||
| Proceeds from sale of noncontrolling interests | — | 2,943 | ||||||
| Dividends paid to Dow Inc. | (771) | (1,237) | ||||||
| Other financing activities, net | — | (6) | ||||||
| Cash provided by (used for) financing activities | (1,618) | 2,943 | ||||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | (76) | 259 | ||||||
| Summary | ||||||||
| Increase in cash, cash equivalents and restricted cash | 320 | 2,491 | ||||||
| Cash, cash equivalents and restricted cash at beginning of period | 3,952 | 2,263 | ||||||
| Cash, cash equivalents and restricted cash at end of period | $ | 4,272 | $ | 4,754 | ||||
| Less: Restricted cash and cash equivalents, included in "Other current assets" | 130 | 145 | ||||||
| Cash and cash equivalents at end of period | $ | 4,142 | $ | 4,609 |
See Notes to the Consolidated Financial Statements.
The Dow Chemical Company and Subsidiaries
Consolidated Statements of Equity
| Three Months Ended | Nine Months Ended | |||||||||||||
| In millions (Unaudited) | Sep 30, 2026 | Sep 30, 2025 | Sep 30, 2026 | Sep 30, 2025 | ||||||||||
| Common Stock | ||||||||||||||
| Balance at beginning and end of period | $ | — | $ | — | $ | — | $ | — | ||||||
| Additional Paid-in Capital | ||||||||||||||
| Balance at beginning of period | 12,135 | 11,362 | 11,957 | 9,626 | ||||||||||
| Stock-based compensation | 83 | 97 | 261 | 293 | ||||||||||
| Sale of membership interest in Diamond Infrastructure Solutions | — | 339 | — | 1,879 | ||||||||||
| Balance at end of period | 12,218 | 11,798 | 12,218 | 11,798 | ||||||||||
| Retained Earnings | ||||||||||||||
| Balance at beginning of period | 11,579 | 13,902 | 11,915 | 16,020 | ||||||||||
| Net income (loss) available for The Dow Chemical Company common stockholder | 459 | 62 | 643 | (1,059) | ||||||||||
| Dividends to Dow Inc. | (257) | (240) | (771) | (1,225) | ||||||||||
| Other | (4) | (2) | (10) | (14) | ||||||||||
| Balance at end of period | 11,777 | 13,722 | 11,777 | 13,722 | ||||||||||
| Accumulated Other Comprehensive Loss | ||||||||||||||
| Balance at beginning of period | (7,662) | (7,826) | (7,660) | (8,110) | ||||||||||
| Other comprehensive income | 8 | 63 | 6 | 347 | ||||||||||
| Balance at end of period | (7,654) | (7,763) | (7,654) | (7,763) | ||||||||||
| The Dow Chemical Company's stockholder's equity | 16,341 | 17,757 | 16,341 | 17,757 | ||||||||||
| Noncontrolling Interests | 1,479 | 1,523 | 1,479 | 1,523 | ||||||||||
| Total Equity | $ | 17,820 | $ | 19,280 | $ | 17,820 | $ | 19,280 |
See Notes to the Consolidated Financial Statements.
| Dow Inc. and Subsidiaries The Dow Chemical Company and Subsidiaries (Unaudited) |
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
Table of Contents
NOTE 1 – CONSOLIDATED FINANCIAL STATEMENTS
Basis of Presentation
Dow Inc. is the direct parent company of The Dow Chemical Company and its consolidated subsidiaries ("TDCC" and together with Dow Inc., "Dow" or the "Company"). The unaudited interim consolidated financial statements of Dow Inc. and TDCC were prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") and reflect all adjustments (including normal recurring accruals) which, in the opinion of management, are considered necessary for the fair presentation of the results for the periods presented. These statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the combined Dow Inc. and TDCC Annual Report on Form 10-K for the year ended December 31, 2025 ("2025 10-K").
As a result of the parent/subsidiary relationship between Dow Inc. and TDCC, and considering that the financial statements and disclosures of each company are substantially similar, the companies are filing a combined report for this Quarterly Report on Form 10-Q. The information reflected in the report is equally applicable to both Dow Inc. and TDCC, except where otherwise noted. Transactions between TDCC and Dow Inc. are treated as related party transactions for TDCC.
Except as otherwise indicated by the context, the term "Union Carbide" means Union Carbide Corporation, a wholly owned subsidiary of the Company. Additionally, the term "Diamond Infrastructure Solutions" means Dow InfraCo, LLC, an entity that owns and operates infrastructure assets at certain Dow locations on the U.S. Gulf Coast and became a consolidated variable interest entity on May 1, 2025. See Note 20 for additional information about Diamond Infrastructure Solutions.
NOTE 2 – RECENT ACCOUNTING GUIDANCE
Accounting Guidance Issued But Not Adopted at September 30, 2026
In November 2024, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2024-03, "Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses," which is intended to improve disclosures about a public business entity's expenses and address requests from investors for more detailed information about the types of expenses in commonly presented expense captions. Such information should allow investors to better understand an entity's performance, assess future cash flows, and compare performance over time and with other entities. The amendments will require public business entities to disclose in the notes to the financial statements, at each interim and annual reporting period, specific information about certain costs and expenses, including purchases of inventory, employee compensation, depreciation, and intangible asset amortization included in each expense caption presented on the face of the income statement, and the total amount of an entity's selling expenses. The amendments are effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027, and may be applied either prospectively or retrospectively. Early adoption is permitted. While the adoption of ASU 2024-03 will result in enhanced disclosures, the Company does not expect it will have a material impact on its financial condition or results of operations.
In September 2025, the FASB issued ASU 2025-06, "Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software," which is intended to modernize the accounting for the costs of internal-use software given the evolution of software development to the incremental and iterative development method. The amendments remove all references to prescriptive and sequential development stages and, instead, require an entity to start capitalizing software costs when management has authorized and committed to funding the software project, and it is probable that the project will be completed and the software will be used to perform the function intended. The amendments are effective for annual reporting periods beginning after December 15, 2027, and interim reporting periods within those annual reporting periods. Early adoption is permitted as of the beginning of an annual reporting period with the amendments to be applied using a prospective, modified or retrospective transition approach. The Company is currently evaluating the impact of adopting this guidance on the consolidated financial statements.
In December 2025, the FASB issued ASU 2025-10, "Government Grants (Topic 832): Accounting for Government Grants Received by Business Entities," which is intended to establish authoritative guidance on the accounting for government grants received by business entities and reduce diversity in practice. The amendments establish the timing and methods of recognition of both (1) a grant related to an asset and (2) a grant related to income. The amendments also require certain disclosures including the nature of the grant received, the accounting policies used to account for the grant, and significant terms and conditions for the grant. The amendments are effective for public business entities for annual reporting periods beginning after December 15, 2028, and interim reporting periods within those annual reporting periods. Early adoption is permitted as of the beginning of an annual reporting period with the amendments to be applied using a modified prospective, modified retrospective or retrospective transition approach. The Company is currently evaluating the impact of adopting this guidance on the consolidated financial statements.
In May 2026, the FASB issued ASU 2026-02, "Environmental Credits and Environmental Credit Obligations (Topic 818)," which is intended to improve the accounting for and disclosure of environmental credits and related obligations and reduce diversity in practice. The amendments establish recognition, measurement, presentation, and disclosure requirements for environmental credits and environmental credit obligations arising from regulatory compliance programs. Environmental credits are recognized as assets when it is probable they will be used to settle an obligation, transferred in an exchange transaction, or used in a nonreciprocal transfer, and are subsequently measured based on their intended use. Environmental credit obligations are recognized as liabilities as qualifying events occur and are measured based on the carrying amount of related credits held and the amount required to settle any shortfall. The amendments are effective for public business entities for annual reporting periods beginning after December 15, 2027, and interim periods within those annual reporting periods. Early adoption is permitted as of the beginning of an annual reporting period with the amendments to be applied on a retrospective basis through a cumulative-effect adjustment to retained earnings. The Company is currently evaluating the impact of adopting this guidance on the consolidated financial statements.
NOTE 3 – REVENUE
Revenue Recognition
The majority of the Company's revenue is derived from product sales. The Company's revenue related to product sales was 98 percent for the three and nine months ended September 30, 2026 (98 percent for the three and nine months ended September 30, 2025). The remaining sales were primarily related to the Company's insurance operations and licensing of patents and technologies. Product sales consist of sales of the Company's products to manufacturers and distributors. The Company considers order confirmations or purchase orders, which in some cases are governed by master supply agreements, to be contracts with a customer. The Company enters into licensing arrangements in which it licenses certain rights of its patents and technology to customers. Revenue from the Company’s licenses for patents and technology is derived from sales-based royalties and licensing arrangements based on billing schedules established in each contract.
Remaining Performance Obligations
Remaining performance obligations represent the transaction price allocated to unsatisfied or partially unsatisfied performance obligations. At September 30, 2026, the Company had unfulfilled performance obligations of $618 million ($617 million at December 31, 2025) related to the licensing of technology. The Company expects revenue to be recognized for the remaining performance obligations over the next six years.
The Company has additional remaining performance obligations for product sales that have expected durations of one year or less, product sales of materials delivered through a pipeline for which the Company has elected the "right to invoice" practical expedient, and variable consideration attributable to royalties for licenses of patents and technology. The Company has received advance payments from customers related to long-term supply agreements that are deferred and recognized over the life of the contract, with remaining contract terms that range up to 18 years. The Company will have rights to future consideration for revenue recognized when product is delivered to the customer. These payments are included in "Accrued and other current liabilities" and "Other noncurrent obligations" in the consolidated balance sheets.
Disaggregation of Revenue
The Company disaggregates its revenue from contracts with customers by operating segment and business, as the Company believes it best depicts the nature, amount, timing and uncertainty of its revenue and cash flows. See details in the tables below:
| Net Trade Sales by Segment and Business | Three Months Ended | Nine Months Ended | ||||||||||||
| In millions | Sep 30, 2026 | Sep 30, 2025 | Sep 30, 2026 | Sep 30, 2025 | ||||||||||
| Hydrocarbons & Energy | $ | 1,656 | $ | 1,233 | $ | 4,597 | $ | 4,161 | ||||||
| Packaging and Specialty Plastics | 4,122 | 3,658 | 12,485 | 11,065 | ||||||||||
| Packaging & Specialty Plastics | $ | 5,778 | $ | 4,891 | $ | 17,082 | $ | 15,226 | ||||||
| Industrial Solutions | $ | 1,150 | $ | 1,004 | $ | 3,219 | $ | 3,043 | ||||||
| Polyurethanes & Construction Chemicals | 1,903 | 1,826 | 5,616 | 5,420 | ||||||||||
| Other | 5 | 4 | 15 | 12 | ||||||||||
| Industrial Intermediates & Infrastructure | $ | 3,058 | $ | 2,834 | $ | 8,850 | $ | 8,475 | ||||||
| Coatings & Performance Monomers | $ | 925 | $ | 809 | $ | 2,780 | $ | 2,518 | ||||||
| Consumer Solutions | 1,325 | 1,273 | 3,911 | 3,764 | ||||||||||
| Performance Materials & Coatings | $ | 2,250 | $ | 2,082 | $ | 6,691 | $ | 6,282 | ||||||
| Corporate | $ | 181 | $ | 166 | $ | 530 | $ | 525 | ||||||
| Total | $ | 11,267 | $ | 9,973 | $ | 33,153 | $ | 30,508 |
| Net Trade Sales by Geographic Region | Three Months Ended | Nine Months Ended | ||||||||||||
| In millions | Sep 30, 2026 | Sep 30, 2025 | Sep 30, 2026 | Sep 30, 2025 | ||||||||||
| U.S. & Canada | $ | 4,548 | $ | 3,914 | $ | 13,126 | $ | 12,129 | ||||||
| EMEAI 1 | 3,637 | 3,090 | 10,751 | 9,636 | ||||||||||
| Asia Pacific | 1,781 | 1,838 | 5,336 | 5,433 | ||||||||||
| Latin America | 1,301 | 1,131 | 3,940 | 3,310 | ||||||||||
| Total | $ | 11,267 | $ | 9,973 | $ | 33,153 | $ | 30,508 |
1.Europe, Middle East, Africa and India.
Contract Assets and Liabilities
The Company receives payments from customers based upon contractual billing schedules. Accounts receivable are recorded when the right to consideration becomes unconditional. Contract assets include amounts related to the Company's contractual right to consideration for completed performance obligations not yet invoiced. Contract liabilities include payments received in advance of performance under the contract and are recognized in revenue when the performance obligations are met. "Contract liabilities - current" primarily reflects deferred revenue from prepayments from customers for product to be delivered in 12 months or less and royalty payments that are deferred and will be recognized in 12 months or less. "Contract liabilities - noncurrent" includes advance payments that the Company has received from customers related to long-term supply agreements and royalty payments that are deferred and recognized over the life of the contract.
Revenue recognized in the first nine months of 2026 from amounts included in contract liabilities at the beginning of the period was approximately $170 million (approximately $170 million in the first nine months of 2025). In the first nine months of 2026 and 2025, the amount of contract assets reclassified to receivables as a result of the right to the transaction consideration becoming unconditional was insignificant.
The following table summarizes contract assets and liabilities at September 30, 2026 and December 31, 2025:
| Contract Assets and Liabilities | Balance Sheet Classification | Sep 30, 2026 | Dec 31, 2025 | ||||||||
| In millions | |||||||||||
| Accounts and notes receivable - trade | Accounts and notes receivable - trade | $ | 5,890 | $ | 4,762 | ||||||
| Contract liabilities - current | Accrued and other current liabilities | $ | 199 | $ | 221 | ||||||
| Contract liabilities - noncurrent | Other noncurrent obligations | $ | 1,744 | $ | 1,727 |
NOTE 4 – RESTRUCTURING AND ASSET RELATED CHARGES - NET
Charges for restructuring programs and other asset related charges, which include asset impairments, are recorded in "Restructuring and asset related charges - net" in the consolidated statements of income. For additional information on the Company's restructuring programs and other asset related charges, see Note 5 to the Consolidated Financial Statements included in the 2025 10-K.
Transform to Outperform
On January 26, 2026, the Dow Inc. Board of Directors ("Board") approved Transform to Outperform, a comprehensive set of actions designed to improve near-term Operating EBITDA by simplifying the Company's operating model, reducing its cost structure and delivering faster growth. The actions, which include a workforce reduction of approximately 4,500 roles, are expected to be substantially complete by the end of 2027. As a result, in the first, second and third quarters of 2026, the Company recorded pretax charges of $27 million, $445 million and $9 million, respectively, for severance and related benefit costs, included in "Restructuring and asset related charges - net" in the consolidated statements of income, related to Corporate.
The Company has recorded pretax inception-to-date charges of $481 million for severance and related benefit costs associated with Transform to Outperform and has made related payments of $214 million.
At September 30, 2026, $255 million of the reserve balance was included in "Accrued and other current liabilities" and $12 million was included in "Other noncurrent obligations" in the consolidated balance sheets.
2025 Restructuring Program
On January 27, 2025, the Board approved targeted actions to further achieve the Company's cost reduction initiatives in response to ongoing macroeconomic uncertainty, while reinforcing its long-term competitiveness across the economic cycle. These actions, which included a workforce reduction of approximately 1,500 roles, were substantially complete at June 30, 2026.
On June 30, 2025, the Board approved restructuring actions to rationalize the Company's global asset footprint, including certain actions identified as part of the Company's previously announced strategic review of its European assets and certain corporate and other assets, and to enhance the Company's competitiveness over the economic cycle. The program includes asset write-down and write-off charges, severance and related benefit costs and other exit and disposal costs. The actions related to the shutdown of these assets are expected to be substantially
complete by the end of 2027, with associated severance and related benefit cost payments continuing primarily through the first quarter of 2030. In the second quarter of 2026, the Company recorded additional pretax restructuring charges of $58 million, consisting of asset write-downs and write-offs of $8 million and costs associated with exit and disposal activities of $50 million related to a supply commitment. The impact of these charges is shown as "Restructuring and asset related charges - net" in the consolidated statements of income. See Note 19 for additional information on nonrecurring fair value measurements.
The following table summarizes the activities related to the 2025 Restructuring Program, including segment information:
| 2025 Restructuring Program | Severance and Related Benefit Costs | Asset Write-downs and Write-offs | Costs Associated with Exit and Disposal Activities | Total | ||||||||||
| In millions | ||||||||||||||
| Corporate | $ | 207 | $ | — | $ | — | $ | 207 | ||||||
| Total restructuring charges | $ | 207 | $ | — | $ | — | $ | 207 | ||||||
| Reserve balance at Mar 31, 2025 | $ | 207 | $ | — | $ | — | $ | 207 | ||||||
| Packaging & Specialty Plastics | $ | — | $ | 81 | $ | 77 | $ | 158 | ||||||
| Industrial Intermediates & Infrastructure | — | 63 | 26 | 89 | ||||||||||
| Performance Materials & Coatings | — | 147 | — | 147 | ||||||||||
| Corporate | 154 | 43 | — | 197 | ||||||||||
| Total restructuring charges | $ | 154 | $ | 334 | $ | 103 | $ | 591 | ||||||
| Charges against the reserve 1 | — | (334) | (103) | (437) | ||||||||||
| Cash payments | (16) | — | — | (16) | ||||||||||
| Reserve balance at Jun 30, 2025 | $ | 345 | $ | — | $ | — | $ | 345 | ||||||
| Packaging & Specialty Plastics | $ | — | $ | 3 | $ | — | $ | 3 | ||||||
| Industrial Intermediates & Infrastructure | — | 1 | 5 | 6 | ||||||||||
| Performance Materials & Coatings | — | 3 | — | 3 | ||||||||||
| Corporate | — | 1 | 10 | 11 | ||||||||||
| Total restructuring charges | $ | — | $ | 8 | $ | 15 | $ | 23 | ||||||
| Charges against the reserve 1 | — | (8) | (15) | (23) | ||||||||||
| Cash payments | (66) | — | — | (66) | ||||||||||
| Reserve balance at Sep 30, 2025 | $ | 279 | $ | — | $ | — | $ | 279 | ||||||
| Packaging & Specialty Plastics | $ | — | $ | 4 | $ | — | $ | 4 | ||||||
| Corporate | 28 | 3 | 6 | 37 | ||||||||||
| Total restructuring charges | $ | 28 | $ | 7 | $ | 6 | $ | 41 | ||||||
| Charges against the reserve 1 | — | (7) | (6) | (13) | ||||||||||
| Cash payments | (44) | — | — | (44) | ||||||||||
| Reserve balance at Dec 31, 2025 | $ | 263 | $ | — | $ | — | $ | 263 | ||||||
| Cash payments | (69) | — | — | (69) | ||||||||||
| Reserve balance at Mar 31, 2026 | $ | 194 | $ | — | $ | — | $ | 194 | ||||||
| Industrial Intermediates & Infrastructure | — | 1 | — | 1 | ||||||||||
| Performance Materials & Coatings | — | 7 | 50 | 57 | ||||||||||
| Total restructuring charges | $ | — | $ | 8 | $ | 50 | $ | 58 | ||||||
| Charges against the reserve | — | (8) | — | (8) | ||||||||||
| Cash payments | (25) | — | — | (25) | ||||||||||
| Reserve balance at Jun 30, 2026 | $ | 169 | $ | — | $ | 50 | $ | 219 | ||||||
| Cash payments | (15) | — | — | (15) | ||||||||||
| Reserve balance at Sep 30, 2026 | $ | 154 | $ | — | $ | 50 | $ | 204 |
1.Costs associated with exit and disposal activities relate to asset retirement obligations and pension benefit settlement costs.
At September 30, 2026, $58 million of the restructuring reserve balance was included in "Accrued and other current liabilities" ($123 million at December 31, 2025) and $146 million was included in "Other noncurrent obligations" ($140 million at December 31, 2025) in the consolidated balance sheets.
The Company recorded pretax restructuring charges of $920 million inception-to-date under the 2025 Restructuring Program, consisting of severance and related benefit costs of $389 million, asset write-downs and write-offs of $357 million and costs associated with exit and disposal activities of $174 million.
Restructuring implementation costs, primarily decommissioning and demolition activities related to asset actions and costs associated with the Company's restructuring actions, are expected to result in additional cash expenditures of approximately $160 million. Restructuring implementation costs totaled $31 million and $80 million for the three and nine months ended September 30, 2026, respectively ($5 million and $10 million for the three and nine months ended September 30, 2025, respectively).
NOTE 5 – SUPPLEMENTARY INFORMATION
| Dow Inc. Sundry Income (Expense) – Net | Three Months Ended | Nine Months Ended | ||||||||||||
| In millions | Sep 30, 2026 | Sep 30, 2025 | Sep 30, 2026 | Sep 30, 2025 | ||||||||||
| Non-operating pension and other postretirement benefit plan net credits 1 | $ | 19 | $ | 36 | $ | 55 | $ | 110 | ||||||
| Foreign exchange gains 2 | 14 | 12 | 74 | 23 | ||||||||||
| Gain related to Nova ethylene asset matter 3 | 69 | — | 95 | — | ||||||||||
| Gain on sales of other assets and investments | 10 | 5 | 69 | — | ||||||||||
| Gain on divestiture of ownership interest in DowAksa 4 | — | 110 | — | 110 | ||||||||||
| Gain on divestiture of soil fumigation product line | — | — | — | 103 | ||||||||||
| Loss on early extinguishment of debt 5 | (53) | (18) | (50) | (78) | ||||||||||
| Indemnification and other transaction related costs | — | (3) | 7 | (20) | ||||||||||
| Other - net | (9) | 43 | 46 | 97 | ||||||||||
| Total sundry income (expense) – net | $ | 50 | $ | 185 | $ | 296 | $ | 345 |
1.See Note 16 for additional information.
2.Foreign exchange gains for the three and nine months ended September 30, 2026 relate primarily to exposures to the Euro. Foreign exchange gains for the three and nine months ended September 30, 2025 relate primarily to exposures to the Euro, partially offset by losses in exposures to the Argentine peso.
3.See Note 12 for additional information.
4.In August 2025, the Company sold its ownership interest in DowAksa Advanced Composites Holdings BV ("DowAksa"), a nonconsolidated affiliate, to its joint venture partner.
5.See Note 11 for additional information.
Sundry income (expense) - net for TDCC for the three and nine months ended September 30, 2026 and 2025 is substantially the same as that of Dow Inc. and, therefore, Sundry income (expense) - net for TDCC is not disclosed separately.
Other Investments
The Company has investments in company-owned life insurance policies, which are recorded at their cash surrender value as of each balance sheet date, as provided below:
| Investments in Company-Owned Life Insurance | Sep 30, 2026 | Dec 31, 2025 | ||||||
| In millions | ||||||||
| Gross cash value | $ | 494 | $ | 543 | ||||
| Less: Existing drawdowns 1 | — | 197 | ||||||
| Less: Accrued interest on drawdowns 2 | — | 2 | ||||||
| Investments in company-owned life insurance 3 | $ | 494 | $ | 344 |
1.Classified as "Proceeds from sales and maturities of investments" in the consolidated statements of cash flows.
2.Included in "Sundry income (expense) - net" in the consolidated statements of income.
3.Classified as "Other investments" in the consolidated balance sheets.
In 2026, the Company repaid its existing drawdown of $197 million, which was included in “Purchases of investments” in the consolidated statements of cash flows.
Supplier Finance Program
The Company facilitates a supply chain financing (“SCF”) program in the ordinary course of business in order to extend payment terms with vendors. Under the terms of this program, a vendor can voluntarily enter into an agreement with a participating financial intermediary to sell its receivables due from the Company. The vendor receives payment from the financial intermediary, and the Company pays the financial intermediary on the terms originally negotiated with the vendor, which generally range from 90 to 120 days. The vendor negotiates the terms of the agreements directly with the financial intermediary and the Company is not a party to that agreement. The financial intermediary may allow the participating vendor to utilize the Company’s creditworthiness in establishing credit spreads and associated costs, which may provide the vendor with more favorable terms than they would be able to secure on their own. The Company does not provide guarantees related to the SCF program. At September 30, 2026, outstanding obligations confirmed as valid under the SCF program were $275 million ($239 million at December 31, 2025), included in “Accounts payable – Trade” in the consolidated balance sheets.
NOTE 6 – INCOME TAXES
As the financial statements for Dow Inc. and TDCC are substantially similar, including the provision for income taxes, the following income tax discussion does not include reference to TDCC's provision for income taxes or its effective tax rate.
The Company's effective tax rate fluctuates based on, among other factors, where income is earned, the level of income relative to tax attributes and the level of equity earnings, since most earnings from the Company's equity method investments are taxed at the joint venture level.
The following table provides effective tax rate information for Dow Inc. for the three and nine months ended September 30, 2026 and 2025:
| Effective Tax Rate Information | Three Months Ended | Nine Months Ended | ||||||||||||
| Amounts in millions | Sep 30, 2026 | Sep 30, 2025 | Sep 30, 2026 | Sep 30, 2025 | ||||||||||
| Income (loss) before income taxes | $ | 642 | $ | 70 | $ | 1,123 | $ | (963) | ||||||
| Provision (credit) for income taxes | $ | 117 | $ | (54) | $ | 241 | $ | 4 | ||||||
| Effective tax rate | 18.2 | % | (77.1) | % | 21.5 | % | (0.4) | % |
The credit for income taxes for the three months ended September 30, 2025 was impacted by the recording of a tax benefit stemming from the U.S. Tax Court's decision in Varian Medical Systems Inc. v. Commissioner of $100 million and a tax benefit of $20 million related to the sale of an additional portion of the Company's membership interests in Diamond Infrastructure Solutions, partially offset by losses attributable to jurisdictions for which no tax benefit can be recognized. The provision for income taxes for the nine months ended September 30, 2025, was also impacted by the recording of valuation allowances in certain foreign jurisdictions of $242 million and losses attributable to jurisdictions for which no tax benefit can be recognized, partially offset by a tax benefit of $89 million related to the initial sale of a portion of the Company's membership interests in Diamond Infrastructure Solutions. These factors resulted in a negative effective tax rate for both periods.
NOTE 7 – EARNINGS PER SHARE CALCULATIONS
The following tables provide earnings per share calculations for Dow Inc. for the three and nine months ended September 30, 2026 and 2025. Earnings per share of TDCC is not presented as this information is not required in financial statements of wholly owned subsidiaries.
| Net Income (Loss) for Earnings Per Share Calculations | Three Months Ended | Nine Months Ended | ||||||||||||
| In millions | Sep 30, 2026 | Sep 30, 2025 | Sep 30, 2026 | Sep 30, 2025 | ||||||||||
| Net income (loss) | $ | 525 | $ | 124 | $ | 882 | $ | (967) | ||||||
| Net income attributable to noncontrolling interests | 67 | 62 | 236 | 113 | ||||||||||
| Net income attributable to participating securities 1 | 4 | 2 | 6 | 9 | ||||||||||
| Net income (loss) attributable to common stockholders | $ | 454 | $ | 60 | $ | 640 | $ | (1,089) |
1.Restricted stock units are considered participating securities due to the Company's practice of paying dividend equivalents on unvested shares.
| Earnings (Loss) Per Share - Basic and Diluted | Three Months Ended | Nine Months Ended | ||||||||||||
| Dollars per share | Sep 30, 2026 | Sep 30, 2025 | Sep 30, 2026 | Sep 30, 2025 | ||||||||||
| Earnings (loss) per common share - basic | $ | 0.63 | $ | 0.08 | $ | 0.88 | $ | (1.53) | ||||||
| Earnings (loss) per common share - diluted | $ | 0.62 | $ | 0.08 | $ | 0.88 | $ | (1.53) |
| Share Count Information | Three Months Ended | Nine Months Ended | ||||||||||||
| Shares in millions | Sep 30, 2026 | Sep 30, 2025 | Sep 30, 2026 | Sep 30, 2025 | ||||||||||
| Weighted-average common shares outstanding - basic | 725.5 | 711.8 | 723.4 | 709.4 | ||||||||||
| Plus dilutive effect of equity compensation plans 1 | 1.9 | 1.4 | 1.4 | — | ||||||||||
| Weighted-average common shares outstanding - diluted | 727.4 | 713.2 | 724.8 | 709.4 | ||||||||||
| Stock units excluded from EPS calculations 2 | 15.6 | 19.3 | 15.9 | 23.6 |
1.The nine months ended September 30, 2025 reflect a net loss and, as such, the basic share count was used for purposes of calculating earnings per share on a diluted basis.
2.These outstanding stock units were excluded from the calculation of diluted earnings per share because the effect of including them would have been antidilutive.
NOTE 8 – INVENTORIES
The following table provides a breakdown of inventories:
| Inventories | Sep 30, 2026 | Dec 31, 2025 | ||||||
| In millions | ||||||||
| Finished goods | $ | 3,901 | $ | 3,737 | ||||
| Work in process | 1,614 | 1,239 | ||||||
| Raw materials | 833 | 826 | ||||||
| Supplies | 1,179 | 1,181 | ||||||
| Total | $ | 7,527 | $ | 6,983 | ||||
| Adjustment of inventories to the LIFO basis | (503) | (388) | ||||||
| Total inventories | $ | 7,024 | $ | 6,595 |
NOTE 9 – NONCONSOLIDATED AFFILIATES
For additional information on the Company’s nonconsolidated affiliates, see Note 11 to the Consolidated Financial Statements included in the 2025 10-K.
The Company's investments in companies accounted for using the equity method ("nonconsolidated affiliates"), by classification in the consolidated balance sheets are shown in the following table:
| Investments in Nonconsolidated Affiliates | Sep 30, 2026 | Dec 31, 2025 | ||||||
| In millions | ||||||||
| Investment in nonconsolidated affiliates | $ | 1,119 | $ | 1,264 | ||||
| Other noncurrent obligations | (796) | (933) | ||||||
| Net investment in nonconsolidated affiliates | $ | 323 | $ | 331 |
At September 30, 2026, the Company had a negative investment balance in Sadara Chemical Company ("Sadara") of $758 million included in "Other noncurrent obligations" (negative $901 million at December 31, 2025) in the consolidated balance sheets. In accordance with ASC Topic 323 "Investments—Equity Method and Joint Ventures," the Company suspended recognition of its share of equity losses from Sadara in the first quarter of 2026, as the carrying value of Sadara related liabilities recorded in Dow’s consolidated balance sheets (primarily the negative investment balance and guarantee liabilities) reached the total of Dow’s existing relevant obligations and commitments. See Notes 12 and 19 for additional information.
At September 30, 2026, the Company had a negative investment balance in EQUATE Petrochemical Company K.S.C.C. of $30 million included in "Other noncurrent obligations" (negative $24 million at December 31, 2025) in the consolidated balance sheets. The increase in the negative investment was driven by dividends distributed to shareholders, net of equity earnings in the first nine months of 2026.
NOTE 10 – TRANSFERS OF FINANCIAL ASSETS
Accounts Receivable Programs
The Company maintains accounts receivable facilities with various financial institutions, with committed and uncommitted facilities in the United States, which are set to expire in November 2028 and committed and uncommitted facilities in Europe, which are set to expire in March 2029 (collectively, "the Programs"). Under the terms of the Programs, the Company may sell certain eligible trade accounts receivable at any point in time, up to $900 million for the U.S. committed facility and up to €400 million for the Europe committed facility. Under the terms of the Programs, the Company continues to service the receivables from the customer, but retains no interest in the receivables, and remits payment to the financial institutions. Losses on transfers of receivables were insignificant for the three and nine months ended September 30, 2026 and 2025. The Company also provides a guarantee to the financial institutions for the creditworthiness and collection of the receivables in satisfaction of the facility. See Note 12 for additional information related to guarantees.
The Company has access to accounts receivable discounting facilities that cover certain receivables generated from sales in EMEAI, Asia Pacific and Canada (collectively, "the Facilities"). Under the terms of the Facilities, the Company retains no interest in the transferred receivables once sold and receivables are transferred with limited recourse. The Company continues to service the receivables from the customer and remits payment to the Facilities. Losses on transfers of receivables were insignificant for the three and nine months ended September 30, 2026 and 2025.
The following table provides a summary of cash flows related to the Programs and the Facilities for the three and nine months ended September 30, 2026 and 2025:
| Cash Flows Related to Transfers of Accounts Receivable | Three Months Ended | Nine Months Ended | ||||||||||||
| In millions | Sep 30, 2026 | Sep 30, 2025 | Sep 30, 2026 | Sep 30, 2025 | ||||||||||
| Proceeds received from new transfers | $ | 6 | $ | — | $ | 6 | $ | 538 | ||||||
The Company did not have any balances recorded in its consolidated balance sheets related to transfers of accounts receivable at September 30, 2026 and December 31, 2025.
NOTE 11 – NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES
| Notes Payable | Sep 30, 2026 | Dec 31, 2025 | ||||||
| In millions | ||||||||
| Notes payable to banks and other lenders | $ | 16 | $ | 90 | ||||
| Period-end average interest rates | 7.55 | % | 32.18 | % |
| Long-Term Debt | 2026 Average Rate | Sep 30, 2026 | 2025 Average Rate | Dec 31, 2025 | |||||||||||||
| In millions | |||||||||||||||||
| Promissory notes and debentures: | |||||||||||||||||
| Final maturity 2028 | 4.80 | % | $ | 600 | 4.80 | % | $ | 600 | |||||||||
| Final maturity 2029 1 | 7.54 | % | 877 | 7.53 | % | 952 | |||||||||||
| Final maturity 2030 | 2.10 | % | 818 | 2.10 | % | 818 | |||||||||||
| Final maturity 2031 | 4.80 | % | 750 | 4.80 | % | 750 | |||||||||||
| Final maturity 2032 and thereafter 1 | 5.33 | % | 10,452 | 5.40 | % | 10,803 | |||||||||||
| Other facilities: | |||||||||||||||||
| Foreign currency notes and loans, various rates and maturities 1 | 1.30 | % | 2,109 | 1.98 | % | 2,237 | |||||||||||
| InterNotes®, varying maturities through 2056 | 5.00 | % | 1,066 | 4.81 | % | 1,011 | |||||||||||
| Financed acquisitions of property | 5.40 | % | 14 | — | % | — | |||||||||||
| Finance lease obligations 2 | 1,044 | 1,126 | |||||||||||||||
| Unamortized debt discount and issuance costs | (207) | (226) | |||||||||||||||
| Long-term debt due within one year 3 | (745) | (222) | |||||||||||||||
| Long-term debt | $ | 16,778 | $ | 17,849 |
1.Cost includes net fair value hedge adjustment losses of $22 million at September 30, 2026 (gains of $27 million at December 31, 2025). See Note 18 for additional information.
2.See Note 13 for additional information.
3.Presented net of current portion of unamortized debt issuance costs.
| Maturities of Long-Term Debt for Next Five Years at Sep 30, 2026 | |||||
| In millions | |||||
| 2026 | $ | 48 | |||
| 2027 | $ | 782 | |||
| 2028 | $ | 765 | |||
| 2029 | $ | 996 | |||
| 2030 | $ | 1,046 | |||
| 2031 | $ | 878 |
2026 Activity
In the second quarter of 2026, the Company redeemed $12 million aggregate principal amount of 6.30 percent notes due March 2033, $10 million aggregate principal amount of 5.65 percent notes due March 2036, $20 million aggregate principal amount of 5.25 percent notes due November 2041, $12 million aggregate principal amount of 5.55 percent notes due November 2048, $10 million aggregate principal amount of 6.90 percent notes due May 2053, and $13 million aggregate principal amount of 5.95 percent notes due March 2055. As a result of the redemption, the Company recognized a pretax gain on the early extinguishment of debt of $3 million, included in "Sundry income (expense) - net" in the consolidated statements of income.
In the third quarter of 2026, the Company redeemed $63 million aggregate principal amount of 7.38 percent notes due November 2029, $13 million aggregate principal amount of 7.85 percent notes due July 2029, $125 million aggregate principal amount of 9.40 percent notes due May 2039, and $99 million aggregate principal amount of 6.90 percent notes due May 2053. As a result of the redemption, the Company recognized a pretax loss on the early extinguishment of debt of $53 million, included in "Sundry income (expense) - net" in the consolidated statements of income, related to Corporate.
In the first nine months of 2026, the Company issued an aggregate principal amount of $100 million of InterNotes®. Additionally, the Company repaid $83 million of long-term debt at maturity.
Available Credit Facilities
The following table summarizes the Company's credit facilities:
| Committed and Available Credit Facilities at Sep 30, 2026 | ||||||||||||||
| In millions | Committed Credit | Available Credit | Maturity Date | Interest | ||||||||||
| Five Year Competitive Advance and Revolving Credit Facility | $ | 5,000 | $ | 5,000 | June 2031 | Floating rate | ||||||||
| Bilateral Revolving Credit Facility | 375 | 375 | October 2026 | Floating rate | ||||||||||
| Bilateral Revolving Credit Facility | 150 | 150 | November 2026 | Floating rate | ||||||||||
| Bilateral Revolving Credit Facility | 200 | 200 | November 2026 | Floating rate | ||||||||||
| Bilateral Revolving Credit Facility | 250 | 250 | March 2027 | Floating rate | ||||||||||
| Bilateral Revolving Credit Facility | 100 | 100 | May 2027 | Floating rate | ||||||||||
| Bilateral Revolving Credit Facility | 350 | 350 | June 2027 | Floating rate | ||||||||||
| Bilateral Revolving Credit Facility | 200 | 200 | September 2027 | Floating rate | ||||||||||
| Bilateral Revolving Credit Facility | 100 | 100 | October 2027 | Floating rate | ||||||||||
| Bilateral Revolving Credit Facility | 200 | 200 | November 2027 | Floating rate | ||||||||||
| Bilateral Revolving Credit Facility | 100 | 100 | March 2028 | Floating rate | ||||||||||
| Bilateral Revolving Credit Facility | 100 | 100 | March 2028 | Floating rate | ||||||||||
| Bilateral Revolving Credit Facility | 300 | 300 | May 2028 | Floating rate | ||||||||||
| Bilateral Revolving Credit Facility | 200 | 200 | September 2028 | Floating rate | ||||||||||
| Bilateral Revolving Credit Facility | 175 | 175 | September 2028 | Floating rate | ||||||||||
| Bilateral Revolving Credit Facility | 300 | 300 | January 2029 | Floating rate | ||||||||||
| Bilateral Revolving Credit Facility | 100 | 100 | June 2030 | Floating rate | ||||||||||
| Total committed and available credit facilities | $ | 8,200 | $ | 8,200 |
Debt Covenants and Default Provisions
There were no material changes to the debt covenants and default provisions related to the Company's outstanding long-term debt and primary, private credit agreements in the first nine months of 2026. For additional information on the Company's debt covenants and default provisions, see Note 14 to the Consolidated Financial Statements included in the 2025 10-K.
NOTE 12 – COMMITMENTS AND CONTINGENCIES
A summary of the Company's commitments and contingencies can be found in Note 15 to the Consolidated Financial Statements included in the 2025 10-K, which is incorporated by reference herein.
Environmental Matters
Accruals for environmental matters are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated, based on current law and existing technologies. At September 30, 2026, the Company had accrued obligations of $991 million for probable environmental remediation and restoration costs ($1,011 million at December 31, 2025), including $233 million for the remediation of Superfund sites ($221 million at December 31, 2025). This is management’s best estimate of the costs for remediation and restoration with respect to environmental matters for which the Company has accrued liabilities, although it is reasonably possible that the ultimate cost with respect to these particular matters could range up to approximately two and a half times that amount. Consequently, it is reasonably possible that environmental remediation and restoration costs in excess of amounts accrued could have a material impact on the Company's results of operations, financial condition and cash flows. It is the opinion of the Company’s management, however, that the possibility is remote that costs in excess of the range disclosed will have a material impact on the Company’s results of operations, financial condition and cash flows. Inherent uncertainties exist in these estimates primarily due to unknown conditions, changing governmental regulations and legal standards regarding liability, and emerging remediation technologies for handling site remediation and restoration. As new or additional information becomes available and/or certain spending trends become known, management will evaluate such information in determination of the current estimate of environmental liability.
Litigation
Asbestos-Related Matters of Union Carbide Corporation
Each quarter, Union Carbide reviews asbestos-related claims filed, settled and dismissed, as well as average settlement and resolution costs by disease category. Union Carbide also considers additional quantitative and qualitative factors such as the nature of pending claims, trial experience of Union Carbide and other asbestos defendants, current spending for defense and processing costs, significant appellate rulings and legislative developments, trends in the tort system, and their respective effects on expected future resolution costs. Union Carbide's management considers these factors in conjunction with the most recent actuarial study and determines whether a change in the estimate is warranted. Based on Union Carbide's review of 2026 activity, it was determined that no adjustment to the accrual was required at September 30, 2026.
Union Carbide’s total asbestos-related liability for pending and future claims and defense and processing costs was $645 million at September 30, 2026 ($708 million at December 31, 2025). At September 30, 2026, approximately 29 percent of the recorded claim liability related to pending claims and approximately 71 percent related to future claims.
Gain Contingency - Dow v. Nova Chemicals Corporation Ethylene Asset Matter
In 2019, the Court of King's Bench of Alberta, Canada ("Court") found Nova Chemicals Corporation ("Nova") liable for engaging in a deliberate and continuing course of conduct of conversion, breach of contract, gross negligence and willful misconduct in the operation of the companies’ jointly-owned ethylene asset in Joffre, Alberta, Canada ("Ethylene Asset"). As a result of the liability finding, which is now final and non-appealable, the Court signed a judgment ordering Nova to pay $1.43 billion Canadian dollars (equivalent to approximately $1.08 billion U.S. dollars) for damages incurred through 2012. Nova made payment in October 2019. At September 30, 2026, $201 million ($201 million at December 31, 2025) was included in "Other noncurrent obligations" in the Company's consolidated balance sheets related to the disputed portion of the 2019 damages judgment.
On June 10, 2025, the Court signed a separate judgment ordering Nova to pay an additional amount of $1.62 billion Canadian dollars (equivalent to approximately $1.2 billion U.S. dollars) for damages incurred through June 2018, which had not been previously quantified. The Court again found that Nova failed to operate the Ethylene Asset at full capacity during this time, depriving the Company’s subsidiaries of millions of pounds of ethylene. On August 11, 2025, the Court also awarded fees of approximately $100 million U.S. dollars, bringing Nova’s payment obligation to approximately $1.3 billion U.S. dollars. In March 2026, after Nova’s procedural attempt to avoid payment and enforcement measures during its pending appeal on damages was denied, Nova paid $1.4 billion Canadian dollars (equivalent to approximately $1.0 billion U.S. dollars) directly to the Company and remitted withholding tax of $452 million Canadian dollars to the Canada Revenue Agency ("CRA") for the tax account of one of the Company's subsidiaries. The Company sought a refund of the withholding tax and, in the third quarter of 2026, the Company received the full refund from the CRA, equivalent to $318 million U.S. dollars.
Certain portions of the damages judgment were not in dispute and, in accordance with ASC 450-30 "Gain Contingencies" ("ASC 450-30"), the Company recorded a $40 million pretax gain in the first quarter of 2026, of which $14 million was included in "Selling, general and administrative expenses" in the consolidated statements of income and $26 million was included in "Sundry income (expense) - net" in the consolidated statements of income and related to Packaging & Specialty Plastics. In the third quarter of 2026, certain additional portions of the damages judgment were considered no longer in dispute and, in accordance with ASC 450-30, the Company recorded a $74 million pretax gain, of which $5 million was included in "Selling, general and administrative expenses" in the consolidated statements of income and $69 million was included in "Sundry income (expense) - net" in the consolidated statements of income and related to Packaging & Specialty Plastics. At September 30, 2026, $1,220 million was included in "Other noncurrent obligations" in the Company's consolidated balance sheets related to the disputed portion of the 2025 damages judgment and related fees.
Dow has filed a similar lawsuit against Nova in the Court to recover damages due to lost ethylene volumes from the operation of the Ethylene Asset after June 2018.
Guarantees
The following table provides a summary of the final expiration, maximum future payments and recorded liability included in the consolidated balance sheets for guarantees:
| Guarantees | Sep 30, 2026 | Dec 31, 2025 | ||||||||||||||||||
| In millions | Final Expiration | Maximum Future Payments | Recorded Liability | Final Expiration | Maximum Future Payments | Recorded Liability | ||||||||||||||
| Guarantees | 2038 | $ | 1,355 | $ | 586 | 2038 | $ | 1,307 | $ | 212 |
Guarantees arise during the ordinary course of business from relationships with customers, accounts receivable facilities and nonconsolidated affiliates when the Company undertakes an obligation to guarantee the performance of others (via delivery of cash or other assets) if specified triggering events occur. With guarantees, such as commercial or financial contracts, non-performance by the guaranteed party triggers the obligation of the Company to make payments to the beneficiary of the guarantee. The majority of the Company’s guarantees relate to debt of nonconsolidated affiliates, which have expiration dates ranging from less than one year to 12 years.
The Company maintains accounts receivable facilities with various financial institutions, with committed and uncommitted facilities in the United States and in Europe. Under the terms of the Programs, the Company continues to service the receivables from the customers, but retains no interest in the receivables, and remits payment to the financial institutions. The Company also has access to accounts receivable discounting facilities, under which receivables are transferred with limited recourse. The Company’s maximum guaranteed liability for the accounts receivable facilities was zero at September 30, 2026 and December 31, 2025.
TDCC has entered into guarantee agreements related to Sadara, a nonconsolidated affiliate. Sadara reached an agreement with its lenders to re-profile its outstanding project financing debt in the first quarter of 2021. In conjunction with the debt re-profiling, TDCC currently guarantees approximately $1.2 billion of principal, and the respective interest, of Sadara’s project financing debt. Based on current market conditions and continued evaluation, the Company believes there is a more than remote probability that some future performance under the project financing guarantee may be required due to uncertainty in Sadara's cash flows. As part of the debt re-profiling, Sadara established a $500 million revolving credit facility guaranteed by Dow, which would be used to fund Dow’s pro-rata share of any potential shortfall. In 2025, Sadara drew $80 million under the revolving credit facility. The term of the revolving credit facility expired in the second quarter of 2026 and the Company remitted cash to satisfy the outstanding $80 million guarantee obligation. This payment is included in "Investments in and loans to nonconsolidated affiliates" in the consolidated statements of cash flows. In the second quarter of 2026, as part of the debt re-profiling commitments, Dow issued a letter of credit for $86 million which expires in the fourth quarter of 2026. See Note 9 for additional information on Dow's investment in Sadara and Note 19 for additional information on fair value measurements.
NOTE 13 – LEASES
For additional information on the Company's leases, see Note 16 to the Consolidated Financial Statements included in the 2025 10-K.
The components of lease cost for operating and finance leases for the three and nine months ended September 30, 2026 and 2025 were as follows:
| Lease Cost | Three Months Ended | Nine Months Ended | ||||||||||||
| In millions | Sep 30, 2026 | Sep 30, 2025 | Sep 30, 2026 | Sep 30, 2025 | ||||||||||
| Operating lease cost | $ | 108 | $ | 104 | $ | 320 | $ | 319 | ||||||
| Finance lease cost | ||||||||||||||
| Amortization of right-of-use assets - finance | 35 | 33 | 105 | 97 | ||||||||||
| Interest on lease liabilities - finance | 13 | 13 | 41 | 37 | ||||||||||
| Total finance lease cost | 48 | 46 | 146 | 134 | ||||||||||
| Short-term lease cost | 93 | 77 | 249 | 244 | ||||||||||
| Variable lease cost | 322 | 304 | 907 | 842 | ||||||||||
| Sublease income | (1) | (3) | (5) | (6) | ||||||||||
| Total lease cost | $ | 570 | $ | 528 | $ | 1,617 | $ | 1,533 |
The following table provides supplemental cash flow and other information related to leases:
| Other Lease Information | Nine Months Ended | |||||||
| In millions | Sep 30, 2026 | Sep 30, 2025 | ||||||
| Cash paid for amounts included in the measurement of lease liabilities: | ||||||||
| Operating cash flows for operating leases | $ | 332 | $ | 329 | ||||
| Operating cash flows for finance leases | $ | 41 | $ | 37 | ||||
| Financing cash flows for finance leases | $ | 99 | $ | 83 | ||||
| Right-of-use assets obtained in exchange for lease obligations: | ||||||||
| Operating leases | $ | 154 | $ | 262 | ||||
| Finance leases | $ | 23 | $ | 202 |
NOTE 14 – ACCUMULATED OTHER COMPREHENSIVE LOSS
The changes in each component of accumulated other comprehensive loss ("AOCL") for the three and nine months ended September 30, 2026 and 2025 were as follows:
| Accumulated Other Comprehensive Loss | Three Months Ended | Nine Months Ended | ||||||||||||
| In millions | Sep 30, 2026 | Sep 30, 2025 | Sep 30, 2026 | Sep 30, 2025 | ||||||||||
| Unrealized Gains (Losses) on Investments | ||||||||||||||
| Beginning balance | $ | (121) | $ | (233) | $ | (173) | $ | (243) | ||||||
| Unrealized gains (losses) on investments | (111) | 63 | (53) | 78 | ||||||||||
| Tax (expense) benefit | 23 | (8) | 17 | (13) | ||||||||||
| Net unrealized gains (losses) on investments | (88) | 55 | (36) | 65 | ||||||||||
| (Gains) losses reclassified from AOCL to net income (loss) 1 | (1) | 3 | (1) | 3 | ||||||||||
| Tax expense (benefit) 2 | — | (1) | — | (1) | ||||||||||
| Net (gains) losses reclassified from AOCL to net income (loss) | (1) | 2 | (1) | 2 | ||||||||||
| Other comprehensive income (loss), net of tax | (89) | 57 | (37) | 67 | ||||||||||
| Ending balance | $ | (210) | $ | (176) | $ | (210) | $ | (176) | ||||||
| Cumulative Translation Adjustments | ||||||||||||||
| Beginning balance | $ | (1,962) | $ | (1,812) | $ | (1,860) | $ | (2,063) | ||||||
| Gains (losses) on foreign currency translation | 31 | (69) | (27) | 186 | ||||||||||
| Tax (expense) benefit | (3) | 47 | (26) | 62 | ||||||||||
| Net gains (losses) on foreign currency translation | 28 | (22) | (53) | 248 | ||||||||||
| (Gains) losses reclassified from AOCL to net income (loss) 3 | (14) | (11) | (35) | (30) | ||||||||||
| Other comprehensive income (loss), net of tax | 14 | (33) | (88) | 218 | ||||||||||
| Ending balance | $ | (1,948) | $ | (1,845) | $ | (1,948) | $ | (1,845) | ||||||
| Pension and Other Postretirement Benefit Plans | ||||||||||||||
| Beginning balance | $ | (5,456) | $ | (5,679) | $ | (5,529) | $ | (5,720) | ||||||
| Gains (losses) arising during the period | (3) | (1) | (3) | — | ||||||||||
| Amortization of net loss and prior service credit reclassified from AOCL to net income (loss) 4 | 47 | 36 | 141 | 88 | ||||||||||
| Tax expense (benefit) 2 | (11) | (7) | (32) | (19) | ||||||||||
| Net loss and prior service credit reclassified from AOCL to net income (loss) | 36 | 29 | 109 | 69 | ||||||||||
| Other comprehensive income (loss), net of tax | 33 | 28 | 106 | 69 | ||||||||||
| Ending balance | $ | (5,423) | $ | (5,651) | $ | (5,423) | $ | (5,651) | ||||||
| Derivative Instruments | ||||||||||||||
| Beginning balance | $ | (123) | $ | (102) | $ | (98) | $ | (84) | ||||||
| Gains (losses) on derivative instruments | 34 | (4) | (20) | (13) | ||||||||||
| Tax (expense) benefit | (6) | 2 | 7 | (4) | ||||||||||
| Net gains (losses) on derivative instruments | 28 | (2) | (13) | (17) | ||||||||||
| (Gains) losses reclassified from AOCL to net income (loss) 5 | 28 | 17 | 50 | 14 | ||||||||||
| Tax expense (benefit) 2 | (6) | (4) | (12) | (4) | ||||||||||
| Net (gains) losses reclassified from AOCL to net income (loss) | 22 | 13 | 38 | 10 | ||||||||||
| Other comprehensive income (loss), net of tax | 50 | 11 | 25 | (7) | ||||||||||
| Ending balance | $ | (73) | $ | (91) | $ | (73) | $ | (91) | ||||||
| Total AOCL ending balance | $ | (7,654) | $ | (7,763) | $ | (7,654) | $ | (7,763) |
1.Reclassified to "Net sales" and "Sundry income (expense) - net."
2.Reclassified to "Provision (credit) for income taxes."
3.Reclassified to "Sundry income (expense) - net."
4.These AOCL components are included in the computation of the net periodic benefit credit of the Company's defined benefit pension and other postretirement benefit plans. See Note 16 for additional information.
5.Reclassified to "Cost of sales," "Sundry income (expense) - net" and "Interest expense and amortization of debt discount."
NOTE 15 – NONCONTROLLING INTERESTS
Ownership interests in the Company's subsidiaries held by parties other than the Company are presented separately from the Company's equity in the consolidated balance sheets as "Noncontrolling interests." The amount of consolidated net income attributable to the Company and the noncontrolling interests are both presented on the face of the consolidated statements of income.
The following table summarizes the activity for equity attributable to noncontrolling interests for the three and nine months ended September 30, 2026 and 2025:
| Noncontrolling Interests | Three Months Ended | Nine Months Ended | ||||||||||||
| In millions | Sep 30, 2026 | Sep 30, 2025 | Sep 30, 2026 | Sep 30, 2025 | ||||||||||
| Balance at beginning of period | $ | 1,507 | $ | 1,361 | $ | 1,514 | $ | 496 | ||||||
| Net income attributable to noncontrolling interests | 67 | 62 | 236 | 113 | ||||||||||
| Distributions to noncontrolling interests 1 | (94) | (89) | (265) | (137) | ||||||||||
| Cumulative translation adjustments | (1) | (5) | (6) | 23 | ||||||||||
| Sale of noncontrolling interests | — | 194 | — | 1,028 | ||||||||||
| Balance at end of period | $ | 1,479 | $ | 1,523 | $ | 1,479 | $ | 1,523 |
- Includes dividends paid to a joint venture of $4 million and $12 million for the three and nine months ended September 30, 2026 (zero and $8 million for the three and nine months ended September 30, 2025) which were reclassified to "Equity in earnings (losses) of nonconsolidated affiliates" in the consolidated statements of income. The three and nine months ended September 30, 2026 also includes $92 million of dividends declared but not paid, included in "Accrued and other current liabilities" in the consolidated balance sheets.
NOTE 16 – PENSION AND OTHER POSTRETIREMENT BENEFIT PLANS
A summary of the Company's pension and other postretirement benefit plans can be found in Note 19 to the Consolidated Financial Statements included in the 2025 10-K.
The Company's funding policy is to contribute to plans when pension laws and/or economics either require or encourage funding. The Company expects to contribute approximately $220 million to its pension plans in 2026, of which $138 million has been contributed through September 30, 2026.
The following table provides the components of the Company's net periodic benefit cost (credit) for all significant plans:
| Net Periodic Benefit Cost (Credit) for All Significant Plans | Three Months Ended | Nine Months Ended | ||||||||||||
| In millions | Sep 30, 2026 | Sep 30, 2025 | Sep 30, 2026 | Sep 30, 2025 | ||||||||||
| Defined Benefit Pension Plans | ||||||||||||||
| Service cost | $ | 9 | $ | 12 | $ | 28 | $ | 33 | ||||||
| Interest cost | 224 | 251 | 674 | 746 | ||||||||||
| Expected return on plan assets | (298) | (324) | (895) | (965) | ||||||||||
| Amortization of prior service credit | (3) | (4) | (10) | (10) | ||||||||||
| Amortization of net loss | 59 | 42 | 178 | 123 | ||||||||||
| Settlement cost 1 | — | 10 | — | 10 | ||||||||||
| Net periodic benefit credit | $ | (9) | $ | (13) | $ | (25) | $ | (63) | ||||||
| Other Postretirement Benefit Plans | ||||||||||||||
| Service cost | $ | 1 | $ | — | $ | 3 | $ | 2 | ||||||
| Interest cost | 8 | 11 | 25 | 31 | ||||||||||
| Amortization of net gain | (9) | (12) | (27) | (35) | ||||||||||
| Net periodic benefit cost (credit) | $ | — | $ | (1) | $ | 1 | $ | (2) |
1.Related to the settlement of certain plan obligations of a European plan resulting from the 2025 Restructuring Program. See Note 4 for additional information.
Except for the settlement cost component related to the 2025 Restructuring Program, which is included in "Restructuring and asset related charges - net" in the consolidated statements of income, the non-service cost components of net periodic benefit cost (credit) are included in "Sundry income (expense) - net" in the consolidated statements of income.
NOTE 17 – STOCK-BASED COMPENSATION
A summary of the Company's stock-based compensation plans can be found in Note 20 to the Consolidated Financial Statements included in the 2025 10-K.
Stock Incentive Plan
The Company grants stock-based compensation to employees and non-employee directors under the 2019 Stock Incentive Plan, as amended (the "2019 Plan"). The Board approved the second amendment to the 2019 Plan to increase the shares authorized for issuance on February 12, 2026, which was approved by the Company's stockholders at the 2026 Annual Meeting of Stockholders held on April 9, 2026.
Most of the Company's stock-based compensation awards are granted in the first quarter of each year. In the first quarter of 2026, Dow Inc. granted the following stock-based compensation awards to employees:
-
1.8 million stock options with a weighted-average exercise price of $32.65 per share and a weighted-average fair value of $8.00 per share;
-
3.2 million restricted stock units with a weighted-average fair value of $32.64 per share; and
-
2.4 million performance stock units with a weighted-average fair value of $35.62 per share.
There was no material grant activity in the second and third quarters of 2026.
Employee Stock Purchase Plan
Under the 2026 annual offering of the 2021 Employee Stock Purchase Plan (the "2021 ESPP"), most employees are eligible to purchase shares of common stock of Dow Inc. valued at up to 10 percent of their annual total base salary or wages. The number of shares purchased will be determined using the amount contributed by the employee divided by the plan price. The plan price of the stock is equal to 85 percent of the fair market value (closing price) of the common stock at March 30, 2026 (beginning) or October 2, 2026 (ending) of the offering period, whichever is lower.
In the first quarter of 2026, employees subscribed to the right to purchase shares under the 2021 ESPP. In October 2026, 2.7 million shares were delivered to employees under the plan.
NOTE 18 – FINANCIAL INSTRUMENTS
A summary of the Company's financial instruments, risk management policies, derivative instruments and hedging activities can be found in Note 21 to the Consolidated Financial Statements included in the 2025 10-K.
Refer to Note 19 for a summary of the fair value of financial instruments at September 30, 2026 and December 31, 2025.
Debt Securities
The Company's investments in debt securities are primarily classified as available-for-sale. The following table provides investing results from available-for-sale securities for the nine months ended September 30, 2026 and 2025:
| Investing Results | Nine Months Ended | |||||||
| In millions | Sep 30, 2026 | Sep 30, 2025 | ||||||
| Proceeds from sales of available-for-sale securities | $ | 402 | $ | 320 | ||||
| Gross realized gains | $ | 11 | $ | 6 | ||||
| Gross realized losses | $ | (10) | $ | (9) |
The following table summarizes contractual maturities of the Company's investments in debt securities:
| Contractual Maturities of Debt Securities at Sep 30, 2026 | Cost | Fair Value | ||||||
| In millions | ||||||||
| Within one year | $ | 54 | $ | 53 | ||||
| One to five years | 1,149 | 1,087 | ||||||
| Six to ten years | 539 | 509 | ||||||
| After ten years | 739 | 600 | ||||||
| Total | $ | 2,481 | $ | 2,249 |
Equity Securities
There was a $10 million reduction to the carrying value of not readily determinable investments resulting from observable price changes and related impairment during the three and nine months ended September 30, 2026. There was $15 million of net unrealized losses recognized in earnings on equity securities for the three months ended September 30, 2026 ($2 million of net unrealized losses for the three months ended September 30, 2025). There were no net unrealized losses recognized in earnings on equity securities for the nine months ended September 30, 2026 ($4 million of net unrealized losses for the nine months ended September 30, 2025).
| Investments in Equity Securities 1 | Sep 30, 2026 | Dec 31, 2025 | ||||||
| In millions | ||||||||
| Readily determinable fair value | $ | 71 | $ | 9 | ||||
| Not readily determinable fair value | $ | 144 | $ | 225 |
1.In 2026, one of the Company’s equity investments that had previously been accounted for as an equity security without a readily determinable fair value completed an initial public offering ("IPO"). Upon consummation of the IPO, the investment obtained a readily determinable fair value based on quoted market prices for the security in an active market.
Derivative Instruments
The notional amounts of the Company's derivative instruments at September 30, 2026 and December 31, 2025 were as follows:
| Notional Amounts 1 | Sep 30, 2026 | Dec 31, 2025 | ||||||
| In millions | ||||||||
| Derivatives designated as hedging instruments: | ||||||||
| Interest rate contracts | $ | 950 | $ | 600 | ||||
| Foreign currency contracts | $ | 4,825 | $ | 5,114 | ||||
| Derivatives not designated as hedging instruments: | ||||||||
| Interest rate contracts | $ | 98 | $ | 97 | ||||
| Foreign currency contracts | $ | 16,950 | $ | 10,560 |
1.Notional amounts represent the absolute value of open derivative positions at the end of the period. Multi-leg option positions are reflected at the maximum notional position at expiration.
The notional amounts of the Company's commodity derivatives at September 30, 2026 and December 31, 2025 were as follows:
| Commodity Notionals 1 | Sep 30, 2026 | Dec 31, 2025 | Notional Volume Unit | ||||||||
| Derivatives designated as hedging instruments: | |||||||||||
| Hydrocarbon derivatives | 2.2 | 9.5 | million barrels of oil equivalent | ||||||||
| Derivatives not designated as hedging instruments: | |||||||||||
| Hydrocarbon derivatives | 0.1 | 1.4 | million barrels of oil equivalent | ||||||||
1.Notional amounts represent the net volume of open derivative positions outstanding at the end of the period.
| Maximum Maturity Dates of Derivatives Designated as Hedging Instruments | Year | ||||
| Interest rate contracts | 2027 | ||||
| Foreign currency contracts | 2027 | ||||
| Commodity contracts | 2028 |
The following table provides the fair value and balance sheet classification of derivative instruments at September 30, 2026 and December 31, 2025:
| Fair Value of Derivative Instruments | Sep 30, 2026 | Dec 31, 2025 | |||||||||||||||||||||
| In millions | Gross | Counterparty and Cash Collateral Netting 1 | Net 2 | Gross | Counterparty and Cash Collateral Netting 1 | Net 2 | |||||||||||||||||
| Asset derivatives | |||||||||||||||||||||||
| Derivatives designated as hedging instruments: | |||||||||||||||||||||||
| Interest rate contracts 3 | $ | 4 | $ | (4) | $ | — | $ | 9 | $ | (9) | $ | — | |||||||||||
| Interest rate contracts 4 | — | — | — | 9 | (8) | 1 | |||||||||||||||||
| Foreign currency contracts 3 | 105 | (52) | 53 | 54 | (32) | 22 | |||||||||||||||||
| Commodity contracts 3 | 474 | (414) | 60 | 171 | (147) | 24 | |||||||||||||||||
| Commodity contracts 4 | 38 | (33) | 5 | 54 | (48) | 6 | |||||||||||||||||
| Total | $ | 621 | $ | (503) | $ | 118 | $ | 297 | $ | (244) | $ | 53 | |||||||||||
| Derivatives not designated as hedging instruments: | |||||||||||||||||||||||
| Foreign currency contracts 3 | $ | 91 | $ | (26) | $ | 65 | $ | 44 | $ | (36) | $ | 8 | |||||||||||
| Commodity contracts 3 | 16 | (11) | 5 | 21 | (17) | 4 | |||||||||||||||||
| Commodity contracts 4 | — | — | — | 2 | — | 2 | |||||||||||||||||
| Total | $ | 107 | $ | (37) | $ | 70 | $ | 67 | $ | (53) | $ | 14 | |||||||||||
| Total asset derivatives | $ | 728 | $ | (540) | $ | 188 | $ | 364 | $ | (297) | $ | 67 | |||||||||||
| Liability derivatives | |||||||||||||||||||||||
| Derivatives designated as hedging instruments: | |||||||||||||||||||||||
| Interest rate contracts 5 | $ | 61 | $ | (4) | $ | 57 | $ | 12 | $ | (9) | $ | 3 | |||||||||||
| Interest rate contracts 6 | — | — | — | 8 | (8) | — | |||||||||||||||||
| Foreign currency contracts 5 | 74 | (52) | 22 | 71 | (32) | 39 | |||||||||||||||||
| Commodity contracts 5 | 457 | (416) | 41 | 182 | (162) | 20 | |||||||||||||||||
| Commodity contracts 6 | 37 | (33) | 4 | 54 | (48) | 6 | |||||||||||||||||
| Total | $ | 629 | $ | (505) | $ | 124 | $ | 327 | $ | (259) | $ | 68 | |||||||||||
| Derivatives not designated as hedging instruments: | |||||||||||||||||||||||
| Interest rate contracts 5 | $ | 1 | $ | — | $ | 1 | $ | 1 | $ | — | $ | 1 | |||||||||||
| Foreign currency contracts 5 | 50 | (26) | 24 | 84 | (36) | 48 | |||||||||||||||||
| Commodity contracts 5 | 20 | (11) | 9 | 21 | (17) | 4 | |||||||||||||||||
| Commodity contracts 6 | 1 | — | 1 | 1 | — | 1 | |||||||||||||||||
| Total | $ | 72 | $ | (37) | $ | 35 | $ | 107 | $ | (53) | $ | 54 | |||||||||||
| Total liability derivatives | $ | 701 | $ | (542) | $ | 159 | $ | 434 | $ | (312) | $ | 122 |
1.Counterparty and cash collateral amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the Company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty.
2.Represents the net amounts included in the consolidated balance sheets.
3.Included in "Other current assets" in the consolidated balance sheets.
4.Included in "Deferred charges and other assets" in the consolidated balance sheets.
5.Included in "Accrued and other current liabilities" in the consolidated balance sheets.
6.Included in "Other noncurrent obligations" in the consolidated balance sheets.
Assets and liabilities related to forward contracts, interest rate swaps, currency swaps, options and other conditional or exchange contracts executed with the same counterparty under a master netting arrangement are netted. Collateral accounts are netted with corresponding assets or liabilities, when applicable. The Company posted cash collateral of $10 million at September 30, 2026 ($20 million at December 31, 2025). No cash collateral was posted by counterparties with the Company at September 30, 2026 and December 31, 2025.
The following table summarizes the gain (loss) of derivative instruments in the consolidated statements of income and comprehensive income for the three and nine months ended September 30, 2026 and 2025:
| Effect of Derivative Instruments | Gain (loss) recognized in OCI 1 | Gain (loss) recognized in income 2 | |||||||||||||||||||||||||||
| Three Months Ended | Nine Months Ended | Three Months Ended | Nine Months Ended | ||||||||||||||||||||||||||
| In millions | Sep 30, 2026 | Sep 30, 2025 | Sep 30, 2026 | Sep 30, 2025 | Sep 30, 2026 | Sep 30, 2025 | Sep 30, 2026 | Sep 30, 2025 | |||||||||||||||||||||
| Derivatives designated as hedging instruments: | |||||||||||||||||||||||||||||
| Fair value hedges: | |||||||||||||||||||||||||||||
| Interest rate contracts 3, 4 | $ | — | $ | — | $ | — | $ | — | $ | (49) | $ | (7) | $ | (49) | $ | 26 | |||||||||||||
| Excluded components 3, 5 | (3) | 7 | (3) | 6 | — | — | — | — | |||||||||||||||||||||
| Cash flow hedges: | |||||||||||||||||||||||||||||
| Interest rate contracts 3 | — | 2 | — | 2 | (1) | (1) | (3) | (2) | |||||||||||||||||||||
| Foreign currency contracts 6 | 7 | (22) | (16) | 8 | 3 | (5) | 2 | — | |||||||||||||||||||||
| Foreign currency contracts 7 | — | 17 | 1 | 2 | — | — | — | — | |||||||||||||||||||||
| Commodity contracts 6 | 24 | (4) | 8 | (15) | (27) | (12) | (44) | (13) | |||||||||||||||||||||
| Excluded components 5, 6 | (1) | — | (4) | — | (3) | (2) | (7) | (5) | |||||||||||||||||||||
| Excluded components 5, 7 | — | — | — | 7 | — | 3 | 2 | 6 | |||||||||||||||||||||
| Net foreign investment hedges: | |||||||||||||||||||||||||||||
| Foreign currency contracts | (11) | — | (7) | (82) | — | — | — | — | |||||||||||||||||||||
| Excluded components 5, 7 | 16 | 10 | 49 | 41 | 14 | 11 | 35 | 30 | |||||||||||||||||||||
| Total derivatives designated as hedging instruments | $ | 32 | $ | 10 | $ | 28 | $ | (31) | $ | (63) | $ | (13) | $ | (64) | $ | 42 | |||||||||||||
| Derivatives not designated as hedging instruments: | |||||||||||||||||||||||||||||
| Interest rate contracts 3 | $ | — | $ | — | $ | — | $ | — | $ | (3) | $ | 2 | $ | (4) | $ | 4 | |||||||||||||
| Foreign currency contracts 7 | — | — | — | — | 10 | 4 | 142 | (208) | |||||||||||||||||||||
| Commodity contracts 6 | — | — | — | — | (8) | (1) | (16) | (18) | |||||||||||||||||||||
| Commodity contracts 7 | — | — | — | — | (2) | (1) | (1) | (1) | |||||||||||||||||||||
| Total return swap 6 | — | — | — | — | (10) | 26 | 19 | 50 | |||||||||||||||||||||
| Total derivatives not designated as hedging instruments | $ | — | $ | — | $ | — | $ | — | $ | (13) | $ | 30 | $ | 140 | $ | (173) | |||||||||||||
| Total derivatives | $ | 32 | $ | 10 | $ | 28 | $ | (31) | $ | (76) | $ | 17 | $ | 76 | $ | (131) |
1.OCI is defined as other comprehensive income (loss).
2.Pretax amounts.
3.Included in "Interest expense and amortization of debt discount" in the consolidated statements of income.
4.Gain (loss) recognized in income of derivatives is offset by gain (loss) recognized in income of the hedged item.
5.The excluded components are related to the time value of the derivatives designated as hedges.
6.Included in "Cost of sales" in the consolidated statements of income.
7.Included in "Sundry income (expense) - net" in the consolidated statements of income.
The following table provides the net after-tax gain (loss) expected to be reclassified from AOCL to income within the next 12 months:
| Expected Reclassifications from AOCL within the next 12 months | Sep 30, 2026 | ||||
| In millions | |||||
| Cash flow hedges: | |||||
| Interest rate contracts | $ | (3) | |||
| Commodity contracts | $ | 29 | |||
| Foreign currency contracts | $ | 6 | |||
| Excluded components | $ | (1) | |||
| Net foreign investment hedges: | |||||
| Excluded components | $ | 23 |
NOTE 19 – FAIR VALUE MEASUREMENTS
A summary of the Company's recurring and nonrecurring fair value measurements can be found in Note 22 to the Consolidated Financial Statements included in the 2025 10-K.
Fair Value Measurements on a Recurring Basis
The following table summarizes the bases used to measure certain assets and liabilities at fair value on a recurring basis:
| Fair Value Measurements on a Recurring Basis | Sep 30, 2026 | Dec 31, 2025 | ||||||||||||||||||||||||||||||
| In millions | Fair Value Level | Cost | Gain | Loss | Fair Value | Cost | Gain | Loss | Fair Value | |||||||||||||||||||||||
| Assets at fair value: | ||||||||||||||||||||||||||||||||
| Cash equivalents: | ||||||||||||||||||||||||||||||||
| Held-to-maturity securities 1 | Level 2 | $ | 824 | $ | — | $ | — | $ | 824 | $ | 624 | $ | — | $ | — | $ | 624 | |||||||||||||||
| Money market funds | Level 2 | 763 | — | — | 763 | 923 | — | — | 923 | |||||||||||||||||||||||
| Marketable securities 2 | Level 2 | 580 | — | (22) | 558 | 446 | — | (61) | 385 | |||||||||||||||||||||||
| Other investments: | ||||||||||||||||||||||||||||||||
| Debt securities: 3 | ||||||||||||||||||||||||||||||||
| Government debt 4 | Level 2 | 1,261 | 12 | (131) | 1,142 | 1,221 | 24 | (83) | 1,162 | |||||||||||||||||||||||
| Corporate bonds | Level 1 | 14 | — | (2) | 12 | 14 | — | (1) | 13 | |||||||||||||||||||||||
| Corporate bonds | Level 2 | 1,006 | 1 | (96) | 911 | 910 | 10 | (57) | 863 | |||||||||||||||||||||||
| Corporate bonds | Level 3 | 200 | — | (16) | 184 | 200 | — | (35) | 165 | |||||||||||||||||||||||
| Equity securities 3, 5 | Level 1 | 34 | 37 | — | 71 | 4 | 5 | — | 9 | |||||||||||||||||||||||
| Derivatives relating to: 6 | ||||||||||||||||||||||||||||||||
| Interest rates | Level 2 | — | 4 | — | 4 | — | 18 | — | 18 | |||||||||||||||||||||||
| Foreign currency | Level 2 | — | 196 | — | 196 | — | 98 | — | 98 | |||||||||||||||||||||||
| Commodities | Level 1 | — | 2 | — | 2 | — | 2 | — | 2 | |||||||||||||||||||||||
| Commodities | Level 2 | — | 526 | — | 526 | — | 246 | — | 246 | |||||||||||||||||||||||
| Total assets at fair value | $ | 5,193 | $ | 4,508 | ||||||||||||||||||||||||||||
| Liabilities at fair value: | ||||||||||||||||||||||||||||||||
| Long-term debt including debt due within one year 7 | Level 2 | $ | (17,523) | $ | 2,269 | $ | (153) | $ | (15,407) | $ | (18,071) | $ | 1,746 | $ | (342) | $ | (16,667) | |||||||||||||||
| Guarantee liability 8 | Level 3 | (500) | (212) | |||||||||||||||||||||||||||||
| Derivatives relating to: 6 | ||||||||||||||||||||||||||||||||
| Interest rates | Level 2 | — | — | (62) | (62) | — | — | (21) | (21) | |||||||||||||||||||||||
| Foreign currency | Level 2 | — | — | (124) | (124) | — | — | (155) | (155) | |||||||||||||||||||||||
| Commodities | Level 1 | — | — | (2) | (2) | — | — | (15) | (15) | |||||||||||||||||||||||
| Commodities | Level 2 | — | — | (513) | (513) | — | — | (243) | (243) | |||||||||||||||||||||||
| Total liabilities at fair value | $ | (16,608) | $ | (17,313) |
1.The Company's held-to-maturity securities primarily relate to treasury bills and time deposits. At September 30, 2026, $772 million is included in "Cash and cash equivalents" ($555 million at December 31, 2025) and $52 million is included in "Other current assets" ($69 million at December 31, 2025) in the consolidated balance sheets.
2.The Company’s investments in marketable securities are included in “Other current assets” in the consolidated balance sheets.
3.The Company’s investments in debt securities, which are primarily available-for-sale, and equity securities are included in “Other investments” in the consolidated balance sheets.
4.U.S. Treasury obligations, U.S. agency obligations, U.S. agency mortgage-backed securities and other municipalities’ obligations.
5.Equity securities with a readily determinable fair value.
6.See Note 18 for classification of derivatives in the consolidated balance sheets.
7.Cost includes fair value hedge adjustment losses of $22 million at September 30, 2026 and gains of $27 million at December 31, 2025 on $5,978 million of debt at September 30, 2026 and $5,538 million of debt at December 31, 2025.
8.Estimated liability for TDCC's guarantee of Sadara's debt, of which $500 million is included in "Other noncurrent obligations" at September 30, 2026 ($132 million at December 31, 2025) and zero is included in "Accrued and other current liabilities" at September 30, 2026 ($80 million at December 31, 2025) in the consolidated balance sheets.
Cost approximates fair value for all other financial instruments.
For equity securities calculated at net asset value per share (or its equivalent), the Company had $102 million in private equity and $11 million in real estate at September 30, 2026 ($109 million in private equity and $13 million in real estate at December 31, 2025). There are no redemption restrictions and the unfunded commitments on these investments were $69 million at September 30, 2026 and $65 million at December 31, 2025.
For assets classified as Level 3 measurements, fair value is based on significant unobservable inputs including assumptions where there is little, if any, market activity. The level 3 asset values represent the fair value of an investment in a corporate bond, accounted for as a debt security.
For liabilities classified as Level 3 measurements, fair value is based on significant unobservable inputs including assumptions where there is little, if any, market activity. The fair value of the Company’s accrued liability related to the guarantee of Sadara’s project financing debt is in proportion to the Company’s 35 percent ownership interest in Sadara. The estimated fair value of the project financing debt guarantee was calculated using a "with" and "without" method. The fair value of the debt was calculated "with" the guarantee less the fair value of the debt "without" the guarantee. The "with" and "without" values were calculated using a discounted cash flow method based on contractual cash flows as well as projected prepayments made on the debt by Sadara. During the three months ended March 31, 2026, the fair value of the project financing debt guarantee liability increased by $298 million, which was included in “Equity in earnings (losses) of nonconsolidated affiliates” in the consolidated statements of income. The increase in fair value was primarily attributable to adverse business conditions impacting Sadara’s operations, including the ongoing conflicts in the Middle East. See Note 12 for further information on guarantees.
NOTE 20 – VARIABLE INTEREST ENTITIES
A summary of the Company's variable interest entities ("VIEs") not discussed below can be found in Note 23 to the Consolidated Financial Statements included in the 2025 10-K.
Assets and Liabilities of Consolidated VIEs
The Company's consolidated financial statements include the assets, liabilities and results of operations of VIEs for which the Company is the primary beneficiary. The other equity holders’ interests are included in “Net income attributable to noncontrolling interests” in the consolidated statements of income and "Noncontrolling interests" in the consolidated balance sheets.
Infrastructure Entity
The Company has variable interests in Diamond Infrastructure Solutions, an entity that owns and operates infrastructure assets at certain Dow locations on the U.S. Gulf Coast. The Company's variable interests relate to its membership interest and the service contracts between Diamond Infrastructure Solutions and Dow, under which a majority of the infrastructure services are provided to Dow using pass-through and cost-plus pricing. Diamond Infrastructure Solutions became a variable interest entity effective with the noncontrolling interest transaction on May 1, 2025. Dow is deemed the primary beneficiary as a result of decision rights held as the majority member.
The following table summarizes the carrying amounts of Diamond Infrastructure Solutions' assets and liabilities included in the Company’s consolidated balance sheets at September 30, 2026 and December 31, 2025. Amounts presented are adjusted for intercompany eliminations.
| Assets and Liabilities of Diamond Infrastructure Solutions | Sep 30, 2026 | Dec 31, 2025 | |||||||||
| In millions | |||||||||||
| Cash and cash equivalents | $ | 244 | $ | — | |||||||
| Other current assets | 171 | 161 | |||||||||
| Net property | 2,235 | 2,273 | |||||||||
| Other noncurrent assets | 192 | 211 | |||||||||
| Total assets 1 | $ | 2,842 | $ | 2,645 | |||||||
| Current liabilities | $ | 479 | $ | 414 | |||||||
| Long-term debt | 173 | 190 | |||||||||
| Other noncurrent obligations | 319 | 351 | |||||||||
| Total liabilities 2 | $ | 971 | $ | 955 |
1.All assets were restricted at September 30, 2026 and December 31, 2025. Cash and cash equivalents held by the consolidated VIE is available for use in the ordinary course of business of the VIE entity and is not classified as restricted cash in the consolidated balance sheets.
2.All liabilities were nonrecourse at September 30, 2026 and December 31, 2025.
Other Consolidated VIEs
In addition, the Company holds variable interests and is the primary beneficiary of other joint ventures and entities. The following table summarizes the carrying amounts of other entities' assets and liabilities included in the Company’s consolidated balance sheets at September 30, 2026 and December 31, 2025. Amounts presented are adjusted for intercompany eliminations.
| Assets and Liabilities of Other Consolidated VIEs | Sep 30, 2026 | Dec 31, 2025 | ||||||
| In millions | ||||||||
| Cash and cash equivalents | $ | 22 | $ | 31 | ||||
| Other current assets | 109 | 253 | ||||||
| Net property | 95 | 112 | ||||||
| Other noncurrent assets | 12 | 15 | ||||||
| Total assets 1 | $ | 238 | $ | 411 | ||||
| Current liabilities | $ | 24 | $ | 24 | ||||
| Other noncurrent obligations | 12 | 13 | ||||||
| Total liabilities 2 | $ | 36 | $ | 37 |
1.Restricted assets totaled $163 million and $194 million at September 30, 2026 and December 31, 2025, respectively. Cash and cash equivalents held by the consolidated VIEs is available for use in the ordinary course of business of the respective VIE entities and is not classified as restricted cash in the consolidated balance sheets.
2.All liabilities were nonrecourse at September 30, 2026 and December 31, 2025.
NOTE 21 – SEGMENTS AND GEOGRAPHIC REGIONS
Sales to external customers, which are attributed to geographic regions based on customer location, were as follows:
| Sales to External Customers by Geographic Region | Three Months Ended | Nine Months Ended | ||||||||||||
| In millions | Sep 30, 2026 | Sep 30, 2025 | Sep 30, 2026 | Sep 30, 2025 | ||||||||||
| United States | $ | 4,260 | $ | 3,651 | $ | 12,234 | $ | 11,322 | ||||||
| EMEAI | 3,637 | 3,090 | 10,751 | 9,636 | ||||||||||
| Rest of World | 3,370 | 3,232 | 10,168 | 9,550 | ||||||||||
| Total | $ | 11,267 | $ | 9,973 | $ | 33,153 | $ | 30,508 |
Long-lived assets, which are attributed to geographic regions based on asset location, were as follows:
| Long-Lived Assets by Geographic Region | Sep 30, 2026 | Dec 31, 2025 | ||||||
| In millions | ||||||||
| United States | $ | 14,227 | $ | 14,804 | ||||
| EMEAI | 2,509 | 2,750 | ||||||
| Rest of World | 5,662 | 4,696 | ||||||
| Total | $ | 22,398 | $ | 22,250 |
Dow’s measure of profit/loss for segment reporting purposes is Operating EBIT as this is the manner in which the chief executive officer, chief financial officer, general counsel, and senior vice president of corporate development, together the chief operating decision maker ("CODM"), assesses performance and allocates resources for the three operating segments. The CODM compares quarterly results to both the year-ago and sequential periods to assess performance and allocate resources to each segment. The Company defines Operating EBIT as earnings (i.e., "Income (loss) before income taxes") before interest, excluding the impact of significant items. Operating EBIT by segment includes all operating items relating to the businesses; items that principally apply to Dow as a whole are assigned to Corporate.
| Segment Operating EBIT 1 | Pack. & Spec. Plastics | Ind. Interm. & Infrast. | Perf. Materials & Coatings | Operating Segment Total | ||||||||||
| In millions | ||||||||||||||
| Three months ended Sep 30, 2026 | ||||||||||||||
| Net sales | $ | 5,778 | $ | 3,058 | $ | 2,250 | $ | 11,086 | ||||||
| Cost of sales | 4,961 | 2,800 | 1,918 | 9,679 | ||||||||||
| SARD 2 | 225 | 112 | 165 | 502 | ||||||||||
| Equity in earnings (losses) of nonconsolidated affiliates | (3) | 11 | 2 | 10 | ||||||||||
| Other segment income (expense) items 3 | (4) | 19 | (15) | — | ||||||||||
| Segment Operating EBIT 4 | $ | 585 | $ | 176 | $ | 154 | $ | 915 | ||||||
| Three months ended Sep 30, 2025 | ||||||||||||||
| Net sales | $ | 4,891 | $ | 2,834 | $ | 2,082 | $ | 9,807 | ||||||
| Cost of sales | 4,474 | 2,714 | 1,851 | 9,039 | ||||||||||
| SARD 2 | 222 | 122 | 158 | 502 | ||||||||||
| Equity in earnings (losses) of nonconsolidated affiliates | (6) | (68) | 1 | (73) | ||||||||||
| Other segment income (expense) items 3 | 10 | 23 | 6 | 39 | ||||||||||
| Segment Operating EBIT 4 | $ | 199 | $ | (47) | $ | 80 | $ | 232 | ||||||
| Nine months ended Sep 30, 2026 | ||||||||||||||
| Net sales | $ | 17,082 | $ | 8,850 | $ | 6,691 | $ | 32,623 | ||||||
| Cost of sales | 14,350 | 8,245 | 5,743 | 28,338 | ||||||||||
| SARD 2 | 704 | 402 | 523 | 1,629 | ||||||||||
| Equity in earnings (losses) of nonconsolidated affiliates | 34 | (5) | 4 | 33 | ||||||||||
| Other segment income (expense) items 3 | 9 | 106 | (25) | 90 | ||||||||||
| Segment Operating EBIT 4 | $ | 2,071 | $ | 304 | $ | 404 | $ | 2,779 | ||||||
| Nine months ended Sep 30, 2025 | ||||||||||||||
| Net sales | $ | 15,226 | $ | 8,475 | $ | 6,282 | $ | 29,983 | ||||||
| Cost of sales | 13,967 | 8,368 | 5,510 | 27,845 | ||||||||||
| SARD 2 | 683 | 365 | 456 | 1,504 | ||||||||||
| Equity in earnings (losses) of nonconsolidated affiliates | 40 | (165) | 2 | (123) | ||||||||||
| Other segment income (expense) items 3 | (4) | 63 | (37) | 22 | ||||||||||
| Segment Operating EBIT 4 | $ | 612 | $ | (360) | $ | 281 | $ | 533 |
1.Significant expense categories are presented on an operating basis, net of the impact of significant items.
2.SARD includes selling, general and administrative and research and development expenses.
3.Other segment income (expense) items includes amortization of intangibles and sundry income (expense) - net.
4.Segment Operating EBIT for TDCC for the three and nine months ended September 30, 2026 and 2025 is substantially the same as that of Dow Inc. and therefore is not disclosed separately in the table above. A reconciliation of "Segment Operating EBIT" to "Income (loss) before income taxes" is provided in the following table.
| Reconciliation of "Segment Operating EBIT" to "Income (Loss) Before Income Taxes" | Three Months Ended | Nine Months Ended | ||||||||||||
| In millions | Sep 30, 2026 | Sep 30, 2025 | Sep 30, 2026 | Sep 30, 2025 | ||||||||||
| Segment Operating EBIT | $ | 915 | $ | 232 | $ | 2,779 | $ | 533 | ||||||
| + Corporate Operating EBIT | (28) | (52) | (90) | (144) | ||||||||||
| + Interest income | 50 | 47 | 130 | 114 | ||||||||||
| - Interest expense and amortization of debt discount | 211 | 221 | 640 | 646 | ||||||||||
| + Significant items | (84) | 64 | (1,056) | (820) | ||||||||||
| Income (loss) before income taxes | $ | 642 | $ | 70 | $ | 1,123 | $ | (963) |
| Other Segment Information | Pack. & Spec. Plastics | Ind. Interm. & Infrast. | Perf. Materials & Coatings | Operating Segment Total | Corp. 1 | Total | ||||||||||||||
| In millions | ||||||||||||||||||||
| Three months ended Sep 30, 2026 | ||||||||||||||||||||
| Net sales | $ | 5,778 | $ | 3,058 | $ | 2,250 | $ | 11,086 | $ | 181 | $ | 11,267 | ||||||||
| Depreciation and amortization | $ | 369 | $ | 147 | $ | 145 | $ | 661 | $ | 5 | $ | 666 | ||||||||
| Capital expenditures | $ | 620 | $ | 37 | $ | 49 | $ | 706 | $ | — | $ | 706 | ||||||||
| Operating EBIT | $ | 585 | $ | 176 | $ | 154 | $ | 915 | $ | (28) | $ | 887 | ||||||||
| Three months ended Sep 30, 2025 | ||||||||||||||||||||
| Net sales | $ | 4,891 | $ | 2,834 | $ | 2,082 | $ | 9,807 | $ | 166 | $ | 9,973 | ||||||||
| Depreciation and amortization | $ | 349 | $ | 158 | $ | 174 | $ | 681 | $ | 7 | $ | 688 | ||||||||
| Capital expenditures | $ | 433 | $ | 72 | $ | 59 | $ | 564 | $ | — | $ | 564 | ||||||||
| Operating EBIT | $ | 199 | $ | (47) | $ | 80 | $ | 232 | $ | (52) | $ | 180 | ||||||||
| Nine months ended Sep 30, 2026 | ||||||||||||||||||||
| Net sales | $ | 17,082 | $ | 8,850 | $ | 6,691 | $ | 32,623 | $ | 530 | $ | 33,153 | ||||||||
| Depreciation and amortization | $ | 1,112 | $ | 432 | $ | 484 | $ | 2,028 | $ | 21 | $ | 2,049 | ||||||||
| Capital expenditures | $ | 1,586 | $ | 118 | $ | 137 | $ | 1,841 | $ | — | $ | 1,841 | ||||||||
| Operating EBIT | $ | 2,071 | $ | 304 | $ | 404 | $ | 2,779 | $ | (90) | $ | 2,689 | ||||||||
| Nine months ended Sep 30, 2025 | ||||||||||||||||||||
| Net sales | $ | 15,226 | $ | 8,475 | $ | 6,282 | $ | 29,983 | $ | 525 | $ | 30,508 | ||||||||
| Depreciation and amortization | $ | 1,078 | $ | 457 | $ | 566 | $ | 2,101 | $ | 25 | $ | 2,126 | ||||||||
| Capital expenditures | $ | 1,458 | $ | 303 | $ | 150 | $ | 1,911 | $ | — | $ | 1,911 | ||||||||
| Operating EBIT | $ | 612 | $ | (360) | $ | 281 | $ | 533 | $ | (144) | $ | 389 |
1.Corporate contains the reconciliation between the totals for the operating segments and the Company's totals. Net sales for Corporate are primarily related to insurance operations. Corporate expenses are primarily related to insurance operations, salaries and wages and non-business aligned environmental and legal costs.
| Segment Asset Information | Pack. & Spec. Plastics | Ind. Interm. & Infrast. | Perf. Materials & Coatings | Operating Segment Total | Corp. | Total | ||||||||||||||
| In millions | ||||||||||||||||||||
| Sep 30, 2026 | ||||||||||||||||||||
| Total assets | $ | 32,233 | $ | 11,141 | $ | 11,836 | $ | 55,210 | $ | 5,743 | $ | 60,953 | ||||||||
| Investments in nonconsolidated affiliates 1 | $ | 614 | $ | 335 | $ | 132 | $ | 1,081 | $ | 38 | $ | 1,119 | ||||||||
| Dec 31, 2025 | ||||||||||||||||||||
| Total assets | $ | 30,251 | $ | 11,263 | $ | 11,407 | $ | 52,921 | $ | 5,617 | $ | 58,538 | ||||||||
| Investments in nonconsolidated affiliates 1 | $ | 677 | $ | 413 | $ | 137 | $ | 1,227 | $ | 37 | $ | 1,264 |
1.See Note 9 for additional information regarding the Company's investments in nonconsolidated affiliates.
The following tables summarize the pretax impact of significant items by segment excluded from Operating EBIT:
| Significant Items by Segment | Pack. & Spec. Plastics | Ind. Interm. & Infrast. | Perf. Materials & Coatings | Operating Segment Total | Corp. | Total | |||||||||||||||||||||||||||||
| In millions | |||||||||||||||||||||||||||||||||||
| Three months ended Sep 30, 2026 | |||||||||||||||||||||||||||||||||||
| Transform to Outperform 1 | $ | — | $ | — | $ | — | $ | — | $ | (69) | $ | (69) | |||||||||||||||||||||||
| 2025 Restructuring Program implementation costs 2 | (1) | — | — | (1) | (30) | (31) | |||||||||||||||||||||||||||||
| Litigation related charges, awards and adjustments 3 | 69 | — | — | 69 | — | 69 | |||||||||||||||||||||||||||||
| Loss on early extinguishment of debt 4 | — | — | — | — | (53) | (53) | |||||||||||||||||||||||||||||
| Total significant items by segment | $ | 68 | $ | — | $ | — | $ | 68 | $ | (152) | $ | (84) | |||||||||||||||||||||||
| Nine months ended Sep 30, 2026 | |||||||||||||||||||||||||||||||||||
| Transform to Outperform 1 | $ | — | $ | — | $ | — | $ | — | $ | (675) | $ | (675) | |||||||||||||||||||||||
| 2025 Restructuring Program asset related charges and exit and disposal costs 5 | — | (1) | (57) | (58) | — | (58) | |||||||||||||||||||||||||||||
| 2025 Restructuring Program implementation costs 2 | (4) | — | — | (4) | (76) | (80) | |||||||||||||||||||||||||||||
| Sadara guarantee liability adjustment 6 | (81) | (211) | — | (292) | — | (292) | |||||||||||||||||||||||||||||
| Litigation related charges, awards and adjustments 3 | 95 | — | — | 95 | — | 95 | |||||||||||||||||||||||||||||
| Loss on early extinguishment of debt 4 | — | — | — | — | (53) | (53) | |||||||||||||||||||||||||||||
| Indemnification and other transaction related credits 7 | — | — | — | — | 7 | 7 | |||||||||||||||||||||||||||||
| Total significant items by segment | $ | 10 | $ | (212) | $ | (57) | $ | (259) | $ | (797) | $ | (1,056) |
1.Includes severance and related benefit costs of $9 million and $481 million for the three and nine months ended September 30, 2026, respectively, and costs to achieve of $60 million and $194 million for the three and nine months ended September 30, 2026, respectively. See Note 4 for additional information related to severance and related benefit costs associated with Transform to Outperform.
2.Includes implementation costs associated with the Company's 2025 Restructuring Program. See Note 4 for additional information.
3.Relates to gains associated with a legal matter with Nova. See Note 12 for additional information.
4.Relates to a loss on the early extinguishment of long-term debt. See Note 11 for additional information.
5.Includes impairment charges related to the write-down of certain manufacturing facilities and other miscellaneous assets and exit and disposal costs associated with the Company's 2025 Restructuring Program. See Note 4 for additional information.
6.Includes a charge due to a change in fair value of the estimated liability associated with the Company's guarantee of Sadara's project financing debt. See Notes 9, 12 and 19 for additional information.
7.Relates to credits associated with agreements entered into with DuPont de Nemours, Inc. ("DuPont") and Corteva, Inc. ("Corteva") as part of the separation and distribution which, among other matters, provides for cross-indemnities and allocations of obligations and liabilities for periods prior to, at and after the completion of the separation. See Note 5 for additional information.
| Significant Items by Segment | Pack. & Spec. Plastics | Ind. Interm. & Infrast. | Perf. Materials & Coatings | Operating Segment Total | Corp. | Total | ||||||||||||||
| In millions | ||||||||||||||||||||
| Three months ended Sep 30, 2025 | ||||||||||||||||||||
| 2025 Restructuring Program severance and related benefit costs and asset related charges 1 | $ | (3) | $ | (6) | $ | (3) | $ | (12) | $ | (11) | $ | (23) | ||||||||
| Implementation costs 2 | — | — | — | — | (5) | (5) | ||||||||||||||
| Net gain on divestitures and asset sale 3 | — | — | — | — | 110 | 110 | ||||||||||||||
| Loss on early extinguishment of debt | — | — | — | — | (18) | (18) | ||||||||||||||
| Total significant items by segment | $ | (3) | $ | (6) | $ | (3) | $ | (12) | $ | 76 | $ | 64 | ||||||||
| Nine months ended Sep 30, 2025 | ||||||||||||||||||||
| Restructuring, implementation and efficiency costs, and asset related charges - net 4 | $ | — | $ | (1) | $ | — | $ | (1) | $ | (50) | $ | (51) | ||||||||
| 2025 Restructuring Program severance and related benefit costs and asset related charges 1 | (161) | (95) | (150) | (406) | (415) | (821) | ||||||||||||||
| Implementation costs 2 | — | — | — | — | (10) | (10) | ||||||||||||||
| Net gain on divestitures and asset sale 3 | — | 103 | — | 103 | 110 | 213 | ||||||||||||||
| Litigation related charges, awards and adjustments 5 | — | — | — | — | 42 | 42 | ||||||||||||||
| Loss on early extinguishment of debt | — | — | — | — | (78) | (78) | ||||||||||||||
| Indemnification and other transactions related costs 6 | — | — | — | — | (115) | (115) | ||||||||||||||
| Total significant items by segment | $ | (161) | $ | 7 | $ | (150) | $ | (304) | $ | (516) | $ | (820) |
1.Includes severance and related benefit costs and impairment charges related to the write-down of certain manufacturing facilities, corporate assets, leased non-manufacturing facilities and other miscellaneous assets associated with the Company's 2025 Restructuring Program. See Note 4 for additional information.
2.Includes implementation costs associated with the Company's 2025 Restructuring Program and the sale of membership interests of Diamond Infrastructure Solutions. See Note 4 for additional information about the Company's 2025 Restructuring Program.
3.Includes a gain on the sale of the Company's ownership interest in DowAksa. The nine months ended September 30, 2025 also includes a gain on the sale of the Company's soil fumigation product line in May 2025.
4.Includes restructuring implementation and efficiency costs associated with the Company's 2023 Restructuring Program and the write-down of certain manufacturing assets, partially offset by an asset related credit adjustment.
5.Includes a gain associated with the reassessment of liabilities for certain accrued legacy agricultural products groundwater contamination matters, partially offset by the settlement of a separate claim related to water storage district legacy groundwater contamination matters.
6.Includes a charge related to an arbitration settlement agreement for historical product claims from a divested business and charges associated with agreements entered into with DuPont and Corteva as part of the separation and distribution which, among other matters, provides for cross-indemnities and allocations of obligations and liabilities for periods prior to, at and after the completion of the separation.
Previous: Cover and table of contents · Next: Item 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.